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...resistant bacteria can be transmitted from food-producing animals such as cattle,
pigs and poultry, and the environment to humans, via the food chain.

Executive Summary
Background
Antimicrobial resistance (AMR) associated with the
food chain is currently a subject of major interest
to many food chain stakeholders. In response
safefood commissioned this report to update our
knowledge of this area and to raise awareness of
the issue. Its primary focus is on the food chain
where it impacts consumer health. This review will
inform and underpin any future action to be taken
by safefood with regard to AMR.
What is antimicrobial resistance?
Antibiotics are important drugs used in the
treatment of bacterial infections in both humans
and animals. Emerging antibiotic resistance
among certain bacteria is now frequently
observed, thereby posing a serious threat to
public health. Once these micro-organisms
become resistant to one or more antibiotics, they
do not respond to therapy.
Some bacteria are naturally resistant, whilst
others become resistant following selection after
prolonged antibiotic use. Reservoirs of resistant
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bacteria may develop in the gastrointestinal (GI)
tracts of food-producing animals following mis-use
of these valuable therapeutic drugs. These resistant
bacteria can be transmitted from food-producing
animals such as cattle, pigs and poultry, and the
environment to humans, via the food chain.
In this report, emphasis has been placed primarily
on those bacteria of animal origin that infect
humans via the food chain. Specifically this
report reviews the scientific data available in
relation to Salmonella spp., verocytotoxigenic
Escherichia coli (VTEC), Campylobacter spp., all of
which are important zoonotic bacteria. The report
summarises information on other AMR bacteria
such as methicillin-resistant Staphylococcus
aureus (MRSA) and Clostridium difficile that may
have a food-borne role that has yet to be defined.
Importantly, the document comments on
commensal bacteria, which inhabit the GI tracts
of animals and humans, these have hitherto
been an unrecognised reservoir of resistance.
Consideration is also given to the role of AMR
in probiotic bacteria and genetically modified
organisms (GMO).

Executive Summary

What causes bacteria to develop AMR and why
is this important for food safety?
It is likely that the emergence of AMR in bacteria
involves a complex series of events in humans,
animals and the environment, occurring over
an extended period. In the past AMR has been
recognised in clinical and veterinary settings alone,
and would never have been linked with the food
chain. We derive much of our food from farmed
animals, a feature that links human and animals
alike. The food chain and the broader environment
provide a convenient route, by which humans can
become infected with AMR bacteria.
Emerging AMR: the potential exposure routes
(1) Food-producing animals & the environment
AMR arises following the mis-use of antibiotics.
Humans are exposed to or acquire AMR bacteria
through selection pressure associated with
prolonged use of these important drugs.
Furthermore, humans may also be exposed
through direct contact with animals and humans
that may be colonised/infected with AMR
bacteria. A lesser recognised route however, is
the food chain which may contain AMR bacteria
derived from food-producing animals or from
cross-contamination during food processing.
In the environment, AMR bacteria can enter the
food chain through the contamination of ground
and surface water, or from the spraying of food
crops with contaminated water containing AMR
bacteria derived from human and animal waste.
Where these crops are not processed further after
harvest, this food source may pose an increased
risk to public health.
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(2) Food processing technologies
Food processing technologies are designed
to reduce the risk of transmission of hazards
including bacteria through the food chain. As
bacteria become resistant, following the stress
imposed through antibiotic selection, they may
evolve and undergo genetic changes which make
these organisms more difficult to eliminate.
This may in turn increase the likelyhood of
transmission through the food chain.
(3)	Use of sanitizing agents & biocides in food
production
Sanitizers are used in the food industry to
eliminate contaminating bacteria that may occur
on food preparation surfaces or equipment in
direct contact with food. Although sanitizers,
biocides and antibiotics kill bacteria, there is
increasing concern that resistance to these
cleaning agents may directly or indirectly be
linked to AMR. Concerns have been expressed
in regard to the application of sanitizers and
biocides in food processing and in domestic
food preparation environments where they may
promote the development and dissemination of
AMR via the human food chain. Currently there is
a need to develop a better understanding of this
relationship (if any).
Human Health Impact
There are a range of human health consequences
from AMR including protracted illness and
even death. Vulnerable patients with impaired
immunity are at greatest risk.

...the primary focus of this report is on food and food processing technology with
particular impact on the consumer-health aspects.

Strategies to reduce the emergence of
AMR bacteria
On the island of Ireland there are two AMR
strategies currently active, the Strategy for
the control of Antimicrobial Resistance in the
Republic of Ireland (SARI) and the Anti Microbial
Resistance Action Plan (AMRAP) in Northern
Ireland. Both SARI and AMRAP recommended the
development of guidance protocols in relation to
the appropriate use of antimicrobials (in humans),
as well as strategies to monitor the supply and
use of antimicrobials in our hospitals and the
community. Education awareness programmes
have been developed which are focussed on
medical professionals, veterinary practitioners
and the general public. These aim to create a
better understanding of AMR and how it links to
our broader society. Managing and controlling
any future emergence of AMR micro-organisms
will require a multi-disciplinary approach with
imputs from all health care professionals and
stakeholders in the food industry.
Recommendations
Based on the current safefood report the
following recommendations were offered in
support of the surveillance infrastructure and
research requirements:
Surveillance:
• Intensify AMR surveillance in the animal
population, across the food chain, and in the
human population
• Integrate the all-island AMR Monitoring
Programme (including prescribing, dispensing
and consumption patterns in human and
animal populations)
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•
•

Promote the prudent use of antimicrobial
agents in animal and human medicine
Establish a forum on AMR and food safety,
including all stakeholders to insure delivery of
the surveillance strategy.

Research:
• Improve our understanding of the impacts
of AMR on current and alternative food
processing technologies
• Food attribution studies should be undertaken
to determine the fraction of food animalassociated AMR infections on the island of
Ireland and to assist with the identification
and prioritisation of hazards posed.

Background and terms of reference of
the report
Background:
There is already considerable activity and
information on antimicrobial resistance (AMR)
at the beginning and end of the human food
chain i.e. veterinary and clinical. However, the
primary focus of this report is on food and food
processing technology with particular impact
on the consumer-health aspects. This theme is
appropriate to the remit of safefood. This area is
under explored, although there is some current
scientific literature on the relationship between
AMR, modern food production and consumer/
food interaction. This review will inform and
underpin any action to be untaken by safefood
on AMR and food safety.

Executive Summary

Terms of reference of the report:
• The prevalence of AMR bacteria (pathogens and
commensals) in the food chain
• The impact of food processing stresses on the
survival and evolution of AMR bacteria within
food; and the transfer of AMR among bacteria
within the food matrix
• The impact of currently used antimicrobials
including disinfectants, sanitizers, surfactants
and related decontamination treatments
• The human health impact of antimicrobial use
in food animals
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...widespread use of antibiotics led to the emergence of antibiotic resistance in
many important pathogens...

1
Introduction
What are antibiotics?

What is antimicrobial resistance?

Antibiotics are low molecular weight microbial
metabolites that can kill or inhibit the growth of
sensitive bacteria. The term ‘antibiotic’ refers to
drugs used to treat infectious diseases in animals,
humans and plants and these substances may be
naturally occurring, semi-synthetic or synthetic.
Most of the drugs in use today were discovered
between the years 1940 and 1970. Chemical
modification of the structure of antibiotics leads to
the development of new compounds with an altered
spectrum of activity. The therapeutic benefit of
antibiotics depends on their selective toxicity.

Definition of resistance
The development of antimicrobial resistance
can be seen as a global problem in microbial
ecology and is the best-known example of a
rapid adaptation of bacteria to a new ecosystem
(Carattoli, 2001). Micro-organisms are ubiquitous
in nature and there is a continuous exchange of
genetic information between bacteria inhabiting
diverse ecological niches including, humans,
animals and the broader environment. Genetic
exchanges, combined with the selection of
partially-resistant microorganisms through
continued exposure to sub-lethal doses of
antibiotics, contribute to the emergence of
groups of intermediate resistant and/or (clinically)
resistant bacteria. The position of clones on the
susceptible/intermediate/resistant continuum
is generally defined on the basis of in vitro
parameters, related to their ability to survive
exposure to a defined concentration of an
antimicrobial compound. Bacterial infections
can be described as being clinically resistant
if they have a low probability of responding to

Widespread use of these drugs led to the
emergence of antibiotic resistance in many
important pathogens (Levy, 2002). This resistance
contributes to higher rates of morbidity and,
in the case of severe bacterial infections,
therapeutic failure (Masterton et al., 2006).
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Bacteria can be defined as being resistant to
an antimicrobial compound, when its MIC is
higher than its wild-type counterpart (EUCAST
in 2000; Acar and Rostel 2001). For this reason,
the ‘epidemiological cut-off values’ will vary
among different species and geographical
regions. Antimicrobial drug resistance can be
defined under a number of headings as follows.
A summary of the mode of action of some
antibiotics is illustrated in Figure 1.

drug treatment, even if the maximum dose of
the antimicrobial compound in question is given
(EUCAST, 2000; Acar and Rostel, 2001). Degrees
of antimicrobial susceptibility/resistance in
clinical isolates are often defined in terms of
the Minimum Inhibitory Concentration (MIC) of
an antimicrobial compound required to prevent
bacterial growth.

Figure 1 Mode of Antibiotic Action
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(quinolones)

Mupirocin
Puromycin

Tetracyclines
Spectinomycin
Streptomycin
Gentamicin, tobramycin
Kanamycin (aminoglycosides)
Amikacin
Notrofurans

Intrinsic resistance
Intrinsic resistance relates to the unique
physiological properties of a micro-organism, in
which their metabolic activity is substantially
unaffected by the presence of an antimicrobial
compound. For example, a bacterium may not
possess a particular metabolic pathway, or
internal structure, normally targeted by the
antimicrobial compound.
Such resistances are generally chromosomally
encoded, and are typically responsible for
observed differences in resistance observed
between genera, species and strains of bacteria.
Intrinsic resistance can be associated with
differences in cell wall structures, the ability
to pump antimicrobial compounds out of
the bacterial cell using efflux pumps, or the
production of enzymes capable of inactivating
antimicrobial compounds within the bacterial
cell (Russell, 2001; Gilbert and McBain, 2003).
Gram-negative bacteria in general have a
higher resistance to antimicrobials than Grampositive bacteria (Russell and Chopra, 1996).
More specifically, Gram-negative bacteria are
intrinsically resistant to penicillin G, a ß-lactam
antibiotic, by virtue of their different structure,
which prevents the antibiotic from accessing the
cell wall. Intrinsic resistance is not considered a
clinical problem because antibiotics were never
intended for use against these resistant bacteria.
Acquired resistance
Acquired resistance, in which a previously
sensitive bacterium becomes resistant, can arise
as a result of (a) a mutation in the organisms’
Deoxyribonucleic acid (DNA), or (b) through
the acquisition of one or more antimicrobial
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resistance genes as a result of horizontal gene
transfer within and between bacterial species.
(a) Mutation in the organisms DNA
De novo emergence i.e. a mutation in the
chromosomal DNA of a house-keeping structural
or regulatory gene (Courvalin and Trieu-Cuot,
2001) occurs approximately once in every one
billion cell divisions (Pallasch, 2003). These
mutations are associated with uncorrected errors
arising during DNA replication. Although rare,
such mutation events occur all too frequently
against the background of the millions of ongoing bacterial replication processes in our
environment. The vast majority of these errors
are disadvantageous to the host bacterium, and
do not persist at cellular or population levels.
However, the smaller number of such genetic
mistakes which are advantageous to the host
bacterium can persist and, through a process of
natural selection, emerge to confer resistance to
many bacteria, presenting significant problems in
clinical medicine.
Emergence of antimicrobial resistance can be
accelerated by several means. Thus, different
members of a bacterial species will mutate at
different rates (Martinez and Baquero, 2002),
e.g. approximately one per cent of E. coli
exhibit a hypermutation phenotype (LeClerc et
al., 1996; Matic et al., 1997). The proportion of
hypermutable strains is much higher in chronic
infections, including cystic fibrosis, chronic
stomach infections (Bjorkman et al., 2001) and
chronic obstructive pulmonary disease (Macia et
al., 2005).

1
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(b) Horizontal gene transfer
Once antimicrobial resistance-conferring genes
have appeared by mutation, they can be mobilised
between strains and species by a processes
of horizontal gene transfer. These processes,
which can occur in the environment (in vitro) or
during infection (in vivo), include conjugation,
transduction and transformation, and can involve
one or more defined genetic elements including:
bacteriophages, plasmids, conjugative transposons
and integrons (Carattoli, 2001). The detailed
mechanisms of these processes are outlined later
in this document and this could be appropriately
regarded as a dynamic process wherein a pool of
resistance genes is being actively shared across the
prokaryotic kingdom.
In line with this view, the term ‘resistome’ has
been coined recently to include all antimicrobial
resistance-encoding genes present in the
environment that are potentially transferable
to pathogenic bacteria (D’Costa et al., 2006).
Therefore, it is important to recognise that
many environments contain a wide range of
non-pathogenic micro-organisms carrying
antimicrobial resistant determinants, can
potentially be transformed to sensitive pathogenic
bacteria under appropriate conditions. This means
that efforts to limit the acquisition of antimicrobial
resistance by human pathogens must recognise
the much wider resistance repertoire that may
be encountered in sewage facilities, animal and
human microbiota (Martinez et al., 2007), foods
and the food processing environments (Mc Mahon
et al., 2007; Walsh et al., 2008).
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Multi-drug resistance
Antimicrobial compounds are divided into
different chemical classes (Figure 1), with each class
containing a group of closely related compounds
or their chemical derivatives, which all act in a
similar manner in susceptible bacteria. Multi-drug
resistance is defined as resistance to three or more
individual classes of antimicrobial compound.
Cross-resistance and cross-selection
Cross-resistance occurs when a single
biochemical mechanism confers resistance to
more than one member of a group of related
antibiotics (i.e. a class). Conversely, antibiotics
belonging to different classes are structurally
dissimilar, having different cellular targets and
are, therefore, usually not subject to crossresistance. As a consequence, resistance is
a class-based phenomenon since it affects
the impact of antibiotics of a particular
group, but not antibiotics belonging to other
classes. However, cross-resistance between
various antibiotic classes can also occur by
two mechanisms, i.e., overlapping targets and
increased drug efflux action (Courvalin and TrieuCuot, 2001).

Once antimicrobial resistance-conferring genes have appeared by mutation, they
can be mobilised between strains and species...

Overlapping targets
Macrolides, lincosamides and streptogramins
(MLSB, including streptogramin B) are
chemically, if quite distantly related (Depardieu
and Courvalin, 2001). However, constitutive
methylation of a single adenine base in ribosomal
RNA confers a high-level of resistance to all
three classes of antibiotics (Fluit et al., 2001).
Clinically, the MLS antibiotics are used primarily
for the treatment of a variety of Gram-positive
infections, especially methicillin-resistant
staphylococci (Zhanel et al., 2001). The increasing
appearance of MLS-resistant strains has
compromised their treatment options in recent
years and as a result many synthetic derivatives
of the macrolides have had to be produced.
Antibiotic efflux
A common mechanism in bacteria is an active
export by membrane-bound efflux transporters
(Poole, 2005; Piddock, 2006; Poole, 2007), by
which bacteria eliminate antibiotics and other
structurally unrelated chemicals, including
dyes, bile salts, anticancer and antifungal drugs
(Neyfakh, 2002). Antimicrobial resistance in overexpressing efflux mutants can be attributed to
two mechanisms, (a) an increase in the expression
of efflux pump activity, or (b) through amino acid
substitution(s), making the pump protein more
efficient at exporting xenobiotic compounds
(Piddock, 2006). Efflux also delays the death
of the bacterium by lowering the intracellular
antibiotic concentration (Yu et al., 2003), thus
providing the bacterium with additional time
for mutation to occur (Courvalin and Trieu-Cuot,
2001). Drug-specific efflux pumps have also
been identified and these are usually associated
with mobile genetic elements, which can be
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transferred between bacteria. In contrast MultiDrug Resistant (MDR) efflux pumps are generally
chromosomally encoded (Poole, 2007). The broad
substrate specificities of these efflux pumps
accounts for the decreased susceptibility in
some bacteria, to ß-lactams, aminoglycosides,
chloramphenicol, fluoroquinolones, MLSB drugs,
tetracycline, trimethoprim, sulfonamides and
other chemical compounds. It is well-established
that MDR efflux pumps confer clinically relevant
resistance to antimicrobial compounds in bacteria
(Poole, 2005).

1
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Hazard identification
Antimicrobial resistance can be considered
a direct hazard when the aetiological agent
involved in infection is an antibiotic resistant
food-borne pathogen. An indirect hazard arises
though the transfer of resistance genes to
another bacterium such as a commensal or
pathogenic organism.
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Relevance to food producing animals
and human health
Until recently antimicrobials have been added
to feed and water to promote growth and limit
infection in food-producing animals. Although,
such supplementation poses minimal risk in
terms of toxicity to the animal, it disturbs the
normal animal flora. The risks associated with
the development of antimicrobial resistance are
increasingly recognised as significant (WHO,
2008). A recent meeting between the Food
and Agriculture Organisation (FAO), the World
Organisation for Animal Health (OIE) and the
World Health Organisation (WHO) (Geneva
in 2003) concluded that the emergence of
antimicrobial resistant organisms associated
with non-human usage of antimicrobials posed
adverse consequences to human health. More
recently, new European Union (EU) regulations
banning the use of antibiotics as growth
promoters in animals have been introduced in an
attempt to reduce the emergence of antibiotic
resistance in the food-chain.

...the emergence of antimicrobial resistant organisms associated with non-human
usage of antimicrobials poses adverse consequences to human health...

Such policies are in accordance with the WHO
recommendations and Codex Alimentarius
Commission guidelines. Many classes of
antimicrobial compound(s) are currently used in
both human and animal therapy, raising concerns
about the possibilities of the development of
resistance in animals, and the direct (contact)
or indirect (food) transfer of such resistance to
humans. Such concerns, coupled with the lack of
newly developed antimicrobial drugs, have led to
the necessity to establish management systems,
to contain and if possible, prevent antimicrobial
resistance. Regulatory measures such as
restriction or banning the use of antimicrobial
compounds for specific purposes, or in specific
animal species, have also been established.
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Two expert meetings convened by the WHO
(2005, 2007) resulted in a classification system
for antimicrobial drugs. Antimicrobial drugs
were determined as ‘critically important’, ‘highly
important’ or ‘important’ on the basis of the
extent to which they were sole therapies:
(i)	one of a limited number to treat serious
human disease and
(ii)	used to treat diseases caused by microorganisms that may be transmitted via
non-human sources or diseases caused by
microorganisms that may acquire resistance
genes from non-human sources (see appendix
for Table 1.)

1
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Resistant organisms, pathogenic to humans, have been recovered from food animals
or their derived products...

2
Antimicrobial agent use in food animals
as a cause of human illness
It has been postulated for some time that
the use of antimicrobial compounds in food
animals may contribute to the emergence of
antimicrobial resistant-related health problems
in humans (Bates, 1997). This hypothesis involves
a number of causation steps a) conditions that
facilitate antimicrobial resistance b) emergence
of antimicrobial resistance in an organism
pathogenic to humans c) human exposure to the
resistant organism d) host susceptibility to the
organism and e) virulence changes associated with
antimicrobial resistance.
There is on-going evidence supporting the
hypothesis through each of the stages individually
or across multiple stages. These are as follows:

Causative steps in antimicrobial
resistance
 onditions that facilitate antimicrobial
C
resistance
Antimicrobial agents are widely used in
food animal production for therapeutic and
prophylactic use, as well as for growth promotion
(Shea et al., 2004). The use of sub-therapeutic
doses in healthy animals for prophylaxis and
growth promotion, coupled with imprecise
dosages given to ill and healthy animals (by
delivery of antimicrobials through feed or water),
facilitates antimicrobial resistance though
selection (Hamer, 2002; Wegener, 2003; Shea et
al., 2004; Rosengren et al., 2008).
Emergence of antimicrobial resistance in an
organism pathogenic to humans
Resistant organisms, pathogenic to humans, have
been recovered from food animals or their derived
products, including:
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2

Antimicrobial agent use in food animals as a cause of human illness

•

Methicillin-resistant Staphylococcus aureus
(MRSA) isolated from cows milk (Leonard and
Markey, 2008)
MRSA in pigs (Armand-Lefevre et al., 2005,
Huijsdens et al., 2006)
resistant Salmonella spp. on egg-shells (Little
et al., 2006)
resistant Salmonella spp. in cow’s milk
(Murphy et al., 2008) and in retail meats
(including chicken, pork, turkey and beef)
(White et al., 2001
Chen et al., 2004) resistant E. faecium in
chickens and pork (Sorenson et al., 2001);
multi-drig resistant Campylobacter spp. in
feedlot cattle (Minihan et al., 2006) and
ß-lactam-resistant E. coli, Salmonella spp. and
Staphylococcus aureus in food animals (Li et
al., 2007)

•
•
•

•

•

In the Netherlands the incidence of
fluoroquinolone resistant Campylobacter spp.
increased from 0 to 14 per cent in broiler chickens,
and from 0 to 11 per cent in farm workers,
following the introduction of enrofloxacin and
saxifloxacin on poultry farms (Hamer, 2002).
The emergence of Vancomycin Resistant
enterococci (VRE) (Kayser, 2003) was attributed
to the use of avoparcin, a growth promoter
chemically related to the glycopeptide antibiotic
vancomycin. In some instances the use of one
antimicrobial compound may give rise to the
development of a MDR phenotype, as several
resistance genes may be linked and transferred
together on a mobile genetic element, (Shea et
al., 2004; Li et al., 2007).
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Human exposure to the organism
Humans can be exposed to antimicrobialresistant bacteria through food derived
from colonised animals, through increasing
antimicrobial resistance in the environment and
through food contamination during processing.
Environmental contamination with resistant
organisms, of surface waters for example, has
also been reported, giving rise to concerns about
direct exposure (Shea et al., 2004). Numerous
outbreaks of resistant infections associated with
food animal sources have been reported, with
some examples provided in Table 2:
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(van Loo et al., MRSA
2007)

The
Netherlands

MRSA

(Wulf et al.,
2008)

The
Netherlands /
International

Organism

Reference

Country

Table 2 Human exposure to resistant bacteria

35 with
NT-MRSA (not
previously
seen in
Netherlands)
49%
hospitalised

N/A

Numbers
affected

Case control
study

Prevalence study
of MRSA carriage
in veterinarians

Study type

Geographical
location of cases
linked to density
of pig farms.
Epidemiological
association with
contact with pigs
(link to contact
with cattle too)

272 participants
at an animal
health conference
were screened
and the rate
of carriage
of MRSA was
12.5%, but the
prevalence from
some countries
was higher:
Italy (61%);
Germany (33%);
Netherlands
(23%); Spain
(18%); Belgium
and France (16%)

Main
observations

Association with
tetracycline use
in pig and cattle
farming reported

Zoonotic source
of MRSA may
contribute
to increasing
Community
Acquired MRSA
(CA-MRSA)
incidence

Comments/
Limitations

Humans can be exposed to AMR bacteria through food from colonised

animals, antimicrobial resistance in the environment and food contamination

during processing.

The
Netherlands

The
Netherlands

(Huijsdens et
al., 2006)

(Voss et al.,
2005)

MRSA

MRSA

2 ill

N/A

Prevalence
study of MRSA
in pig farmers
compared with
general Dutch
population

MRSA
investigation
following child
hospitalised

6 humans
Netherlands
associated
MRSA control
with pig-farm
programme uses
colonised.
“search and
8 of 10 pigs MRSA destroy” and
positive
these findings
Identical strains
raise concerns
about new source
of MRSA

More evidence
of pig farming
as a new source
of MRSA, which
might threaten
the effectiveness
of MRSA control
programmes in
the health sector

6/26 (23%) of
pig farmers
screened were
colonised with
MRSA showing
increased
prevalence
of MRSA as
compared with
the general Dutch
population
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Europe –
Iceland,
England &
Wales, The
Netherlands,
Scotland and
Germany

(Crook et al.,
2003)

Salmonella
Typhimurium
DT204b
International
outbreak
investigations
– case control
studies in two
countries
International
outbreak
investigations
– case control
studies in two
countries
In Iceland, link
with imported
lettuce.
History of S.
Typhimurium
DT204b
associated
with bovine
antibiotic use,
and decreased
ciprofloxacin
sensitivity found
associated with
fluoroquinolone
use in agriculture
No phage typing
in Iceland.
Late
identification
of outbreak as
international.
No analytical
epidemiology
in some of the
countries and no
overall outbreak
investigation.
Enternet
surveillance
networks assisted
recognition of
outbreak

Numerous outbreaks of resistant infections associated with food animal sources

have been reported.
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Europe –
Iceland,
England &
Wales, The
Netherlands,
Scotland and
Germany

Denmark

(Crook et al.,
2003)

(Helms et al.,
2002)

Salmonella
Typhimurium
DT204b

Salmonella
Typhimurium.
(susceptible
and resistant)

392 patients –
16% hospitalised
(at least 11% –
hospitalisation
status not
ascertained for
all)

953 pansusceptible
1094 cases
resistant

Matched cohort
study

International
outbreak
investigations
– case control
studies in two
countries

In Iceland, link
No phage typing
with imported
in Iceland
lettuce
Late
History of S.
identification
Typhimurium
of outbreak as
DT204b
international
associated
No analytical
with bovine
epidemiology
antibiotic use,
in some of the
and decreased
countries and no
ciprofloxacin
overall outbreak
sensitivity found investigation
associated with
Enternet
fluoroquinolone
surveillance
use in agriculture. networks assisted
recognition of
outbreak

Adjusted for
co-morbidities
Used population
registers

Cases with pansusceptible
Salmonella
Typhimurium
2.3 x more likely
to die within 2
years compared
with general
population; with
increased risk of
death to 10.3x
for quinolone
resistant
Salmonella
Typhimurium
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(Campylobacter
Sentinel
Surveillance
Scheme
Collaborators,
2002)

(Fey et al.,
2000)

(Grein et al.,
1999)

England/
Wales

US- Nebraska

Ireland

Salmonella
Typhimurium
DT104

Salmonella –
ceftriaxone
resistant

Ciprofloxacin
resistant
Campylobacter
jejuni

Lab testing of
faecal samples

Retrospective
cohort analysis

58 cases
7 hospitalised

Surveillance

Hospitalised
child

>650 notified
cases

Epidemiological
link with turkey
– traceback
found Salmonella
Typhimurium
DT104 in young
turkeys in the
originating
poultry farm

Child’s isolate
the same strain
as cattle samples
from family /
neighbour herds

Domestic cases
associated with
pre-cooked cold
meats; cases with
recent foreign
travel history
associated with
consuming
chicken

Additional
information
about the
contribution of
S. Typhimurium
to burden of
disease – 54%
of all cases, and
80% of these
multiresistant

No herd antibiotic
use information
available

Enhanced
surveillance
data collection
limited, so not
all exposure
questions
answered

Denmark

(Molbak et al., Salmonella
1999)
Typhimurium
DT104.
Quinolone
resistant

US – California (Cody et al.,
1999)

Salmonella
Typhimurium
DT104

Matched case
control studies

27 cases,
Surveillance
11 hospitalised, – Outbreak
2 died
investigation

31 Outbreak 1
79 Outbreak 2
13%
hospitalised

Epidemiological
link to raw
milk cheeses –
Mexican-style.
Link to one dairy
– incomplete
investigation as
second implicated
diary never visited.
Outbreak 2
only came to
light during
case finding for
Outbreak 1

Outbreak linked
to pork from 1
slaughterhouse,
and to 2 linked
swine herds
microbiologically
– PFGE identical
strains. Link
supported by
exposure history
of majority of
cases
Small number
of occupational
or nosocomial
exposures

Limited
laboratory
resources for
typing.
Late
environmental
investigation
hampered
findings

Quinolone
resistance
hampered
treatment with
some treatment
failures, including
in 1 patient who
died
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US

(Glynn et al.,
1998)

Salmonella
spp. /
Salmonella
Typhimurium
DT104
39,032
Salmonella
spp.
3903
salmonellae in
study
Surveillance;
also
National
Salmonella
antimicrobial
resistance study
Of 1326 sent
for typing, 25%
of which were
Salmonella
Typhimurium
of which 34%
were multidrug resistant.
In study, 25%
of 3903 were S.
Typhimurium,
and 28% of these
were five drug
resistant
Trends showed
increasing
proportion of
Salmonella were
multi-drug
resistant.
Issues of
standardisation
of typing /subtyping discussed
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 ost susceptibility and host vulnerability to
H
the organism
The normal host immune response offers
considerable protection against many infections,
but patients with compromised immune systems
are more vulnerable to these illnesses. Extremes
of age are a recognised risk factor associated
with increased vulnerability, as are underlying
illnesses, including chronic disease, and prior
antimicrobial treatment (Shea et al., 2004).
Other host factors may include: a long hospital
stay, intensive care unit stay, having a urinary or
vascular catheter; and antibiotic therapy (Kayser,
2003). Use of proton pump inhibitors was also
found to be a risk factor for S. Typhimurium
DT104 (OR11.2, 95% CI 3.9-31.9) (Doorduyn et
al., 2006). No vaccines are currently available
to protect humans against antimicrobialresistant organisms, including Salmonella spp.,
Campylobacter spp. or MRSA (Chin, 2000).
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No vaccines are currently available to protect humans against antimicrobialresistant organisms...

Virulence changes associated with antimicrobial resistance
The development of an antimicrobial resistance
has been linked with increased virulence in some
pathogenic organisms. This observation may be
explained by the fact that the genes encoding
resistance and virulence are located on plasmids,
or other transmissible elements (Foley and Lynne,
2008). The use of antimicrobial compounds may coselect for virulence in these cases (Molbak, 2005).
Enterococci form part of the normal
gastrointestinal flora of animals and humans
and some of these organisms are used in the
manufacture of food or as probiotics. More
recently, however, enterococci have emerged as
important nosocomial pathogens with some
strains being resistant to several antimicrobials.
Following the introduction of avoparcin, a
glycopeptide growth promoter (chemically
related to and conferring cross-resistance to
vancomycin) in Europe in 1974, resistance to this
agent began to emerge among isolates recovered
from animals, the food supply and urban and
rural sewage supplies (Bager et al., 1997). This
development is now linked with VRE in animals.
These organisms can be transmitted from the
intestinal tracts of animals to humans. Using
molecular sub-typing approaches, an association
has been demonstrated between the use of the
growth promoter avoparcin in animals and VRE
cases in humans.

35

Many antimicrobial resistant bacterial infections
involve longer hospitalisations and increased
mortality (Angulo et al., 2004). The Centers for
Disease Control and Prevention (CDC) review
of 2004 provided evidence of the association
between the use of antimicrobial agents in food
animals and human illness (Angulo et al., 2004).

 elationship between antimicrobial
R
use in animals and human illness
The majority of the evidence acquired through
outbreak and epidemiological investigations of
sporadic infections, field studies, case reports,
ecological and temporal associations and
molecular sub-typing studies (Table 2) support
the causal link between the use of antimicrobial
agents in food animals and human illness. A few
papers have questioned this but these have not
survived detailed scrutiny.

2
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Micro-organisms have developed seven major mechanisms to evade the
bactericidal or bacteriostatic actions of antibiotics.

3
Antimicrobial resistance
Mechanisms of antimicrobial
resistance
Micro-organisms have developed seven major
mechanisms to evade the bactericidal or
bacteriostatic actions of antibiotics. These
mechanisms are listed in Table 3 and the main
mechanisms are illustrated in Figure 2.
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Table 3 Mechanisms of antibiotic resistance.
(Adapted from Pallasch, 2003)
Enzymatic antibiotic inactivation
ß-lactamases: ß-lactams (penicillins, cephalosporins) Acetyltransferases: aminoglycosides,
chloramphenicol and streptogramins
Modification/ protection of target sites
Modified penicillin binding proteins: ß-lactams
Altered DNA gyrase and topoisomerase IV: fluoroquinolones
Altered RNA polymerase: Rifampin
Methylation of an adenine of 23S rRNA: erythromycin, clindamycin, streptogramins
Alteration of 16S rRNA: tetracyclines
Altered tetrahydrofolate and dihydrofolate reductase: sulfonamides and trimethoprim
Substitution of terminal peptidoglycan alanine with lactate: vancomycin and teicoplanin
Limiting antibiotic access to microbial cell
Altered outer membrane porins/reduced membrane transport: most antibiotics
Active efflux
Antibiotic efflux proteins: tetracyclines, fluoroquinolones
Failure to activate antibiotic
Decreased flavodoxin production: metronidazole
Development of alternate growth requirements
Production of auxotrophs: enterococci
Overproduction of target sites
Hyper ß-lactamase production: enteric bacilli
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Horizontal gene transfer may occur by various mechanisms including conjugation,
transduction and transformation.

Figure 2 Mechanisms of microbial resistance to antibiotics

Antibiotic-resistance Antibiotic-efflux
Pump
Genes
Antibiotic-degrading
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B
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C

Plasmid
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Bacterial
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Antibiotic-Altering
Enzyme

Antibiotic

Chromosome

Adapted from: (Levy, 1998), a) efflux pumps, b) antibiotic degrading enzyme and c) antibiotic altering enzyme
Plasmid Donor

Mechanisms of transmission-Horizontal
Resistance
gene transfer
Gene

Transfer may occur by various mechanisms
including conjugation, transduction
and
C
transformation (see Figure
3). In addition, the
Transfer
or
Free
contribution of transposable
DNA elements and
integrons linked to plasmids has been reported
Gene goes
(Carattoli, 2001). Transposons and integrons
to Plasmis
or to
accelerate the development of bacterialChromosome
resistance
Dead
by assisting
in the accumulation, expression and
Bacterium
dissemination of resistant genes.

Plasmid

These features support the onward transmission
of antibiotic resistance genes to daughter cells
by replication Resistance
or Gene
transfer within or among
A
other
bacterial
species,
typically by conjugation
Plasmid
Transfer 2003).
(Carattoli,

Resistance
Gene
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Figure 3 Transferable antibiotic resistance mechanisms in bacteria
Plasmid Donor
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Resistance
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A
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B
Transfer by
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Resistance
Gene
Bacterium
Infected
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Adapted from: (Levy, 1998), (a) conjugation, (b) transduction and (c) transformation
Plasmid
A plasmid is an extrachromosmal genetic
element, which can maintain and express genes
of interest, similar to the chromosome. However,
the genes encoded on a plasmid are not usually
present on the bacterial chromosome and
typically confer a specialised function (i.e. an
R-plasmid confers antimicrobial resistance), which
can improve the cell's adaptability, survival and
growth (Martinez and Baquero, 2002).
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Plasmids also have the ability to multiply
independently of the bacterial chromosome and,
in many cases, contain the necessary information
for their independent transfer from cell to cell,
between and among different species and genera
of bacteria (Wilson, 2000). Thus, the original
host may retain some of the multiple plasmids,
while one or more copies can be transferred
to additional recipient host bacterial cells.
Antibiotic resistance is carried on sections of
plasmids called transposons, or jumping genes.
Transposons are able to jump out of one plasmid

Antibiotic resistance is carried on sections of plasmids called transposons, or
jumping genes.

and into another, carrying antibiotic resistance
with them (Carattoli, 2003). They can also jump
from a plasmid to the bacterial chromosome
and back again. By this means, plasmids can
accumulate resistance to an increasing number of
antibiotics, which are then easily available to be
transposed within and between bacterial species.
Conjugation
Conjugation requires the donor to have a
particular type of plasmid or a transposon to
mobilise the donor DNA, recognise/bind a
suitable recipient and transfer the gene(s) of
interest (Day, 1998). There are four different
classes of plasmid-borne integrons that carry
antibiotic resistance genes. Each integron
carries a distinct integrase gene, of which class
1 integrons are the most common. The 3’-ends
of class 1 integrons usually carry sul1, a gene
coding for sulfonamide resistance. This class of
integron can carry a varying number of up to nine
gene cassettes. Class 2 integrons are different
and usually carry three gene cassettes (dfr1a,
sat1, aadA1), which include a dfr gene encoding
trimethoprim resistance.
Co-trimoxazole resistance is reported to signal
the presence of integrons (Leverstein-van Hall et
al., 2003). Strains with integrons have a higher
chance of being resistant to aminoglycosides,
quinolones and ß-lactams. Class 3 and 4
integrons have only been observed in a few
cases in Japan and India, respectively. Integrons
have the ability to capture genes, notably those
encoding antibiotic resistance by site-specific
recombination (Carattoli, 2003). Integrons have
an integrase gene (int), a distal recombination
site (attl) and a promoter (Pant), which flanks
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a central region wherein gene cassettes are
recombined (Hier et al., 2004). More than 60
different gene cassettes have been identified,
with some integrons possessing multiple
cassettes arranged in tandem and recombined in
a classical head-to-tail orientation (Mazel et al.,
2000). As these resistance determinants are under
the control of a single promoter all recombined
gene cassettes are subsequently co-expressed.
Thus, selective pressure for one determinant by
the use of a particular antibiotic, will co-select for
resistance determinants encoded by downstream
cassettes. This is also important in light of the
fact that integrons (and also transposons) have
been shown to possess a number of genetic
determinants encoding resistance to Quaternary
Ammonium Compounds (QACs) and heavy
metals (Olsen, 1999). This suggests the possibility
that, exposing integron-carrying bacteria to
sub-inhibitory levels of QACs, may co-select for
antibiotic resistant bacteria in the absence of
antibiotics (White et al., 2003).
Transduction
Transduction is the movement of DNA from one
bacterium to another via bacteriophages (bacterial
viruses). This usually occurs when a virus picks up
resistant DNA from one bacterial cell and injects
it into another (Smyth et al., 2003). Phage particles
can protect DNA during transfer, as they generally
show higher levels of resistance to adverse
environmental conditions than free DNA (Day, 1998).
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Transformation
Transformation is an active and dedicated process
of gene exchange, governed by chromosomal genes
that allow the uptake of exogenous free DNA by
a competent cell (Smith et al., 2003). Competence
is often a transient and tightly-regulated process,
through which a proportion of a population passes
due to physiological changes occurring within
those populations (Day, 1998). It is a mechanism
of widespread, but not universal, gene exchange
among bacterial strains (Wolfgang et al., 1999).
Many transformable bacteria release DNA during
growth. Thus, at least 50 different bacteria have
been demonstrated as competent to acquire
genes released into the environment from other
microbes, plants, yeasts and animals (Havarstein,
1998). Genes gained following transduction and/or
transformation must be integrated into a plasmid or
chromosome to be functional (Levy, 1998).

Effect of food processing
technologies
The frequent isolation of MDR isolates from food
sources, suggests that antibiotic resistant genes
are present in a wide variety of different bacterial
species found in food. This raises the question
as to whether or not antibiotic resistance and
sensitive bacteria respond differently to food
processing stresses like heat and acid (Humphrey,
2001). Does antibiotic resistance confer crossresistance to other food-related stresses, or
does it impose a fitness cost, making antibiotic
resistant cells more susceptible to such stresses?
Increased resistance to low pH environments
would raise concern about the stability and
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safety of dairy and fruit juice products. Increased
resistance to thermal stress would be of concern
in relation to a wide range of mildly heat-treated
foods, in particular meat products. Accurate
information on potential changes in response
to food processing parameters is especially
important when considering low infectious
dose pathogens, such as, E. coli O157, where
the presence of even a small number of cells
could be clinically significant. Very little data
is available in this area and the small number
of reports available present conflicting results.
This is unfortunate, as accurate information is
essential to allow food processors to effectively
eliminate undesirable pathogens from food, with
minimum damage to the nutritional, organoleptic
and visual properties of the product. Precise
processing parameters may be necessary to gain
the best possible balance between food safety
and food quality.
A further concern is that sublethal food
processing stress could play a role in the
development and persistence of antibiotic
resistance/MDR, through the action of the
Multiple Antibiotic Resistance operon or by
increasing the rate of horizontal plasmid transfer
(including MDR plasmids). For example, food
processing-related stresses can cause increases in
DNA damage, reductions in the efficiency of DNA
repair and increases in membrane permeability.
It is speculated that these stresses can result in
the development of antibiotic resistance within
the bacterial cell, including the release/transfer
of antibiotic resistant determinants to other cells
(Lado and Yousef, 2002). The current evidence for
these concerns will be discussed in detail later in
this report.

The frequent isolation of MDR isolates from food sources, suggests that antibiotic
resistant genes are present in a wide variety of different bacterial species found
in food.

Antimicrobial resistance and bacterial fitness
The development and/or acquisition of AMR
enables host cells to survive in otherwise hostile
(antimicrobial containing) environments. The more
chromosomal and/or plasmid-borne genes the
host carries, the more energy it has to expend in
maintaining and replicating this heavier compliment
of genes, making the host less efficient and
generally less competitive compared to susceptible
cells carrying fewer resistance genes. Such
reductions in bacterial fitness can for example,
reduce host growth rates, leading to overgrowth
by leaner, antibiotic susceptible strains. However,
slower growth is also related to increased resistance
to other unrelated environmental stresses, including
those used in food processing (McMahon et al.,
2007). It is therefore possible that the increasing
incidence of AMR may have significant implications
for the food production and processing industry,
by reducing the efficiency of food preservation
techniques, and reducing current safety margins
within the food industry. AMR-associated
increases in resistance to common food processing
interventions, such as the application of low/high
temperature, water activity (aw) reduction or pH
modulation is of particular concern in the safe
production and preservation of minimally-processed
foods. Such foods, which form an expanding
fraction of our total food supply, are welcomed by
consumers as fresh and natural. However, these
operate within fairly narrow margins of safety which
could be breached by the slight increases in bacterial
resistance to environmental stress which may be
associated with the acquisition of a resistance
marker. This means that accurate up-to-date
information on antimicrobial resistance and their
impacts on bacterial fitness are essential to assure
safe food processing and preservation schemes.
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A number of studies have reported that
chromosomal AMR mutations, do not confer a
fitness cost during growth (Gustafsson et al.,
2003), heat treatment (Walsh et al., 2001; Duffy et
al., 2006; Walsh et al., 2006), or at low pH (Tkalcic
et al., 2000). However, other studies suggest that
some chromosomal AMR strains do incur a small,
but observable, fitness cost (Sander et al., 2002).
Fitness costs have also been observed during
growth (Blackburn and Davies, 1994; Gustafsson
et al., 2003), heat treatment (Doherty et al., 1998)
and survival at low pH (McGee, 2003) in a variety
of different strains although such fitness costs
may decline (partially or totally) in subsequent
bacterial generations. For this reason fitness
costs incurred during the initial development
of resistance, may be rapidly reduced by
compensatory mutation (Maisnier-Patin et al.,
2002). Such compensation has been reported to
occur in either in vivo or in vitro studies (Björkman
et al., 2000; Reynolds, 2000). Other studies report
compensation through a variety of secondary
mutations, resulting in increased fitness (overcompensation), i.e. the emergence of organisms
with enhanced survival characteristics (Reynolds,
2000) including superior growth rates (Ince and
Hooper, 2003) and virulence (Bjorkman, 1998).
The relationship between AMR and fitness will be
discussed further for each foodborne pathogens
in this report.
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Salmonella enterica is a major cause of bacterial enteric illness in humans
and animals...

4
Specific organisms
Salmonella – Major pathogenic
bacterial hazards
Non-typhoidal Salmonella
Introduction
Salmonella enterica is a major cause of bacterial
enteric illness in humans and animals and is
notably the second leading cause of zoonotic
infection in the European Union (Gupta et al.,
2004). Human infection can also be acquired
through direct contact with carrier domestic
or wild animals, or through consumption of
contaminated foods.
Description of species
Salmonella spp. are Gram-negative, facultatively
anaerobic rods, which are usually motile by
peritrichous flagella. Their optimal growth
temperature is 37˚C, during which D-glucose
and other carbohydrates are metabolised with
the production of acid and (usually) H2S gas.
However, they do not utilise urea (Holt et al.,
1994). Salmonella spp. are oxidase negative,
catalase positive, indole and Voges-Proskauer
negative, methyl red and Simmons citrate
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positive (Madigan et al., 2000). They are readily
killed by heat and acid and are resistant to both
freezing and drying, particularly in the presence
of proteins and protectants. This genus prefers
pH values between 4 and 8 and requires a water
activity of 0.93 and above (Baird-Parker, 1990).
They are found to occur in humans, warm and
cold blooded animals, food and the environment.
They are pathogenic to humans and many
other animal species (Tietjen and Fung, 1995).
The infectious dose can be as few as 15-20 cells,
depending on age, health of the host and strain
differences among the members of the genus.
Salmonella spp. can cause typhoid fever, enteric
fever, gastroenteritis and septicaemia (Holt et al.,
1994).
Salmonella in food on the island of Ireland
In 2006, 1.3 per cent of the raw poultry meat
tested at the processing level was positive for
S. enterica, followed by 5.3 per cent in 2007.
This slight increase was the first observed
since Salmonella spp. contamination rates were
reported to be declining in 2001. This increase was
not mirrored in poultry meat products, as
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only a marginal difference (0.2%) was evident
between 2006 (0.3%) and 2007 (0.5%). No
contamination was reported at retail level in 2006
and very low levels of contamination (0.1%) were
observed similarly in 2007 (Table 4). The most
frequently isolated serotypes from poultry meat
and associated products in 2006, were S. Agona
(16%), S. Kentucky (15%) and S. Mbandaka (15%),
followed by S. Kentucky (75%), S. Agona (10%) and
S. Enteritidis (4%) in 2007.
S. enterica was not isolated from any of the
1,190 egg or egg products sampled in 2006. In
2007, one isolate (0.1%) of the 809 egg and egg
products sampled, was found to be positive for
Salmonella spp. (S. Agona) (Table 4).
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S. enterica was identified in 1.7 per cent of raw
pork and 0.5 per cent of pork products sampled
at processing in 2006. Higher rates of recovery
were observed at a processing level in 2007, as
2.9 per cent of raw pork and 0.7 per cent of pork
products tested positive for S. enterica (Table 4).
S. Typhimurium was the most frequently isolated
serotype from pork and pork meat products in
2006 and 2007 (48% and 45% of all the serotypes
identified, respectively) (FSAI Zoonosis Report
2009). A relatively low proportion (0.06 to 0.2%)
of beef, veal and associated products were
found to be contaminated with S. enterica at the
processing level, compared to none at the retail
level in 2006 and 2007 (Table 4). Of the S. enterica
isolates recovered, S. Typhimurium (37% of
serotypes in 2006 and 34% in 2007) and S. Dublin
(37% of serotypes in 2006 and 20% of 2007) were
the most predominant serotypes recovered in
both years (FSAI Zoonosis Report 2009). In 2006
and 2007, a low incidence (0.01 to 0.8%) of S.
enterica was recovered from other meat and meat
products at the processing level, and none at
retail. S. Typhimurium was found to make up 32
and 22 per cent of the S. enterica strains isolated
in 2006 and 2007, respectively (Table 4).

Salmonella most commonly isolates from raw poultry meat compared to
other meats.

Table 4 Salmonella spp. in food products in the ROI 2005
Food type

Sampling site

Tested 2006

Positive 2006

Tested 2007

Positive 2007

Raw poultry
meat*

Processing
level*
Retail level

6,477
8

84
(1.3% 0)

5,976
4

319 (5.3%)
0

Poultry meat
products

Processing
level
Retail level

6,698
1,378

22 (0.3%)
0

5,578
1,281

27 (0.5%)
1 (0.1%)

Table eggs

148

0

104

1 (0.1%)

Egg products

1042

0

1667

0

Raw pork meat Processing
level

2,929

51 (1.7%)

2,015

58 (2.9%)

Pork meat
products

Processing
level
Retail level

9,053
943

46 (0.5%)
1 (0.1%)

9,111
951

59 (0.7%
0 (0%))

Processing
level
Retail level

21,644
3

36 (0.2%)
0

23,003
38

27 (0.1%)
0

Beef/veal meat Processing
products
level
Retail level

13,783
491

25 (0.2%)
0

13,768
389

8 (0.06%)
0

Poultry

Eggs & Egg Products

Pork & Pork Products

Beef & Veal
Raw beef /veal
meat
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Other meat & meat products
Fresh Meat
Sheep meat
Sheep meat
	Unspecified
meat
	Unspecified
meat
Meat Products
Sheep meat
Sheep meat
	Unspecified
Unspecified

Processing
Retail
Processing
Retail

Processing
Retail
Processing
Retail

1,506
2
2,273
2

2 (0.1%)
0
21(0.8%)
0

1,532
0
3498
0

2 (0.1%)
0
13(0.4%)
0

781
57
5,540
332

0
0
1(0.01%)
0

782
35
5035
361

0
0
9(0.2%)
0

(Source: FSAI, 2009)

Epidemiology of Salmonella spp. on the island of
Ireland and in Europe
In 2007, there were 456 reported cases of
salmonellosis (10.8 cases/100,000 population)
in the Republic of Ireland (ROI), indicating a
small increase in incidence from 2006 (10.0
cases/100,000 population) (HPSC, 2009). The
highest age-specific incidence rate was in
children 0-4 years of age (35.7 cases/100,000
population) with 24 per cent of all cases occurring
in this age-group. As in previous years, cases
peaked between July and October.

48

In Northern Ireland (NI), 159 cases of salmonellosis
were confirmed in 2007 and 186 cases in 2008
(provisional data) (CDSCNI, 2009).
In Europe, 151,995 cases of salmonellosis were
reported in 2007 (31.1 cases/100,000 population),
showing a 7.3 per cent decrease from the previous
year (EFSA, 2009). As seen for the ROI, the highest
age-specific incidence rate was found in children
aged 0-4 years of age (125.4 cases/100,000
population).

In Europe 151,995 cases of salmonellosis were reported in 2007, the highest agespecific incidence rate was found in children 0-4 years of age.

Serotypes
S. Enteritidis (n=179) and S. Typhimurium (n=114)
remain the two most predominant serotypes
(39% and 25% respectively) involved in human
illness in the ROI in 2007. Other serotypes
included; S. Newport (n=13), S. Kentucky (n=9),
S. Typhi (n=8), S. Java (n=8) and S. Infantis (n=8).
Eight isolates of S. Typhi and five of S. Paratyphi
A isolates were detected in 2007, as opposed to
seven S. Typhi isolates and one S. Paratyphi A
isolate in 2006.
In NI (and the UK) the most common serotypes
in human infection were S. Enteritidis and
Typhimurium (EFSA 2006). In the EU, S. Enteritidis
was reported at 65 per cent and S. Typhimurium
at 17 per cent of cases (EFSA, 2009).
Food
The National Reference Laboratory (NRL)
(Department of Agriculture Fisheries and Food,
2008) for Salmonella spp. typed 1,475 isolates of
Salmonella spp. in 2007. These were recovered
through official control programmes or submitted
by private laboratories supporting food safety
controls operated by food business operators. Of
the isolates detected, S. Kentucky was the most
prevalent (n=612), followed by S. Typhimurium (195),
S. Derby (99) and S. Agona (93), with 26 strains of S.
Enteritidis also being isolated.
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However, the most recent UK wide outbreak of
salmonellosis (148 cases to date, September 2008)
was caused by S. Agona which was present in a
range of contaminated sandwich fillers supplied
by a single food company. This outbreak became
Europe-wide, matching the distribution of
contaminated material (www.hps.scot.nhs.uk).
The serotypes most commonly isolated from
animals are species dependent (Table 5), with S.
Dublin the most prevalent serotype in cattle, S.
Diarizonae in sheep, S. Livingstone in chickens and
S. Typhimurium in pigs. S. Rissen and S. Mbandaka
are the serotypes most commonly isolated from
animal feed-stuff, however S. Typhimurium, S.
Enteritidis and S. Hafar have been isolated on a few
occasions (DEFRA, 2006). Although the Salmonella
spp. serotypes most commonly associated
with human salmonellosis are not the most
prevalent serotypes found in animals, the fact
that pathogenic Salmonella spp. serotypes can be
cultured from animals is a cause for concern and
perhaps suggests that there may be a connection
via the food chain or via animal contact.
In the EU, isolates from meat were commonly
resistant to ampicillin, nalidixic acid,
streptomycin and tetracycline with variations in
the levels of resistance in food animals, being
reported in different member states (EFSA, 2006).
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Table 5 S. enterica serotypes present in UK animals and food. (Adapted from Ong et al., 2007)
Source

Prevalent Salmonella
spp.
serotypes (% isolates
reported)

% resistant to antibiotics
Fully SS

Te

Chl

Human
infection

Enteritidis (68%)
Typhimurium (20.8%)

72.3$

7-38%*

1-4%*

Chicken
UK

Livingstone (17.5%)
Senftenburg (12.3%)

44%

22%

8%

Cattle UK

Dublin (60.5%)
Typhimurium (21.5%)

73%

20%

Sheep UK

Diarizonae (71.4%)
Typhimurium (8%)

92%

Turkey UK

Typhimurium Derby

Pig UK

Typhimurium (66.2%)
Derby (13.9%)

Cip
Ceph.

Amino
glycocides

8-15%

0-98%*

0%

<1%

22%

18%

0%

0%

12%

81%

47%

0%

0%

63%

50%

39%

14%

0%

0%

31%

11%

81%

47%

0%

0%

63%

Retail eggs Enteritidis (3.3%)
non-UK
Retail eggs Salmonella spp (0.38%)
UK
Feedstuff

Rissen, Mbandaka

Fully SS = susceptible to all antimicrobials examined
Data consolidated from DEFRA 2006, with additional information from
* AMR 2004
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3rd

The emergence of MDR in Salmonella spp. is considered an important evolutionary
step in the epidemiology of salmonellosis.

Recent surveys for the presence of Salmonella
spp. on raw meat products in NI indicated a
high incidence of Salmonella spp. (40%) on
post-eviceration pig carcasses (McDowell et al.,
2007). A study of the prevalence of Salmonella
spp. in the pork chain on the island of Ireland,
reported that, Salmonella spp. was recovered
from 24 of 720 (3.3%) pork cuts in boning halls
of pork abattoirs in the ROI and from 44 of 525
(8.38%) of pork cuts in NI. The difference in
prevalence in both jurisdictions was not found to
be statistically significant. Furthermore, a study
of the prevalence of Salmonella spp. on retail
pork cuts found Salmonella spp. present in 13 of
500 (2.6%) pork samples purchased in butchers
shops or supermarkets in ROI. In comparison,
Salmonella spp. was recovered from 11 of 200
(5.5%) pork samples purchased in butchers
shops or supermarkets in NI. S. Typhimurium
(approximately 50%) and S. Derby (approximately
20%) were the most dominant serotypes.
A recent report noted that four per cent of raw
chicken contained Salmonella spp. in retail raw
chicken in NI, (Meldrum and Wilson, 2007). In
contrast to an earlier study by Soultos et al.
(2003), this report represents an increase of 1.5 per
cent. The incidence in beef is unknown (no data
available), although Salmonella spp. were recently
isolated from three per cent of faeces from postslaughter (healthy) cattle (Madden et al., 2007). No
data is available on the incidence of Salmonella
spp. in eggs in NI, although it is thought to be
low with similar rates to those reported in the
UK – a direct result of the widely-adopted flock
vaccination regime. A recent survey of Salmonella
spp. in eggs on the island of Ireland, reported only
two isolates (S. Infantis, S. Montevideo on egg
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shells) recovered from 30,000 samples (Murchie
et al., 2007), confirming that domestic (UK/Irish)
produced eggs are currently unlikely to present a
significant source of human salmonellosis.
Antimicrobial resistance in Salmonella spp.
Salmonella enterica continues to be an important
cause of gastroenteritis with an increase reported
in the ROI, NI, England and Wales in the year
2007. S. Typhimurium DT104 is perhaps the bestknown and most widely studied serotype of
Salmonella spp. because of its MDR phenotype.
The emergence of MDR in Salmonella spp. is
considered an important evolutionary step in
the epidemiology of salmonellosis. Until recently
S. Typhimurium DT104 could be distinguished
from other Salmonella spp. isolates, by the
presence of Salmonella genomic Island (SgI1). This
genomic island, typically confers resistance to
five antimicrobials (ampicillin, chloramphenicol,
streptomycin, sulphonamides and tetracycline;
ACSSuT) and has the ability to capture and stably
maintain additional genes, encoding other
antibiotic resistance determinants. As the SgI1 is
chromosomally located, it is stably maintained
in the absence of selective pressure. This feature
continues to drive the emergence of new
variants of S. Typhimurium DT104 with reduced
susceptibility to a larger repertoire of antibiotics.
Moreover, the presence of the SgI1 is linked to
higher rates of morbidity/mortality (Mulvey et al.,
2006). Recent reports of the dissemination of SgI1
among other serotypes of Salmonella spp. and
Proteus are alarming, particularly with regard to
major pathogens of the developing world, such
as, S. paratyphi (Velge et al., 2005). The presence
of the SgI1 limits therapeutic options, particularly
in the developing world where chloramphenicol
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Reports in the EU found similar resistance profiles
(ACSSuT) in Salmonella spp., with additional
resistance to the quinolones and nalidixic acid
(EFSA, 2008).

is the antibiotic of choice as it is cheap and broad
spectrum.
Many S. Typhimurium isolates recovered in the
ROI in 2007, were found to have a resistance
profile typical of that conferred by the presence
of the SGI-1 (63% resistant to ampicillin, 64%
to sulphonamide, 71% to tetracycline, 61% to
streptomycin and 42% to chloramphenicol).
In comparison, for NI, there is no recent data
available for antimicrobial resistant profiles.

MDR is prominent in the Salmonella spp.
population in the ROI (see Table 6). Reports of
antibiotic resistance in clinical samples in the ROI
confirms that MDR resistance in S. Typhimurium
is a growing problem, with resistance to
trimethoprim and nalidixic acid also emerging.
Similar resistance profiles are appearing in other
serotypes (S. Stanley and S. Typhi), mostly likely
as a result of transfer of the SgI1 (see Table 6).

Table 6 AMR of human S. enterica serotypes isolated in the ROI 2006. (Adapted from EPI-Insight, 2007a)
% Of Isolates Resistant to Antibiotics
Serotype (No. Isolates)

AMP

CHL

STREP

SULPH

TET

TRIM

NAL

Enteritidis (158)

8

0.6

2

2

0.6

0.6

0

Typhimurium (101)

69

58

64

68

66

6

6

Agona (5)

20

0

20

40

20

0

40

Virchow (10)

30

20

30

60

50

60

100

Hadar (11)

45

0

100

18

100

18

45

Stanley (6)

33

0

50

50

50

33

0

Typhi (7)

43

43

43

43

0

43
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Kentucky (4)

25

0

25

25

25

0

25

Bredeney (6)

0

0

0

0

0

0

0
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Reports of antibiotic resistance in clinical samples in the ROI confirms that MDR
resistance in S. Typhimurium is a growing problem...

With regard to the western world, the
emergence of resistance to extended spectrum
cephalosporins (antibiotics used in the treatment
of complicated Salmonella spp. in infants) is cause
for concern. Extended spectrum celphalosporin
resistance was first identified in S. Virchow in
Belgium, resulting in a national increase in the
prevalence of S. Virchow. Approximately one year
after detection of this phenotype, this strain
was isolated from poultry meat and humans.
This strain was also resistant to tetracyclines,
sulphonamides, trimethoprim and nalidixic acid
in Europe and in the ROI (Table 7). The emergence
of resistance to nalidixic acid is also of concern
since it is the first step of a two-step mutational
resistance to fluoroquinolones, the first choice
antibiotics for treatment of Salmonella spp.
infection in adults.
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The emergence of cephalosporin resistance can
be seen in many Salmonella spp. serotypes in
Europe including S. Agona, S. Derby, S. Paratyphi
B, S. Typhimurium and of particular concern S.
Infantis. While typically S. Infantis is reported to
be resistant solely to cephalosporins, resistance
is located on a transposon on a self-transmissible
plasmid, indicating the possibility of
dissemination to other serotypes. In conjunction,
cephalosporin resistance is most prevalent in S.
Infantis in poultry.
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Table 7a Antimicrobial susceptibility testing of Salmonella spp. in animals in the ROI
N = Number of resistant isolates
S. Typhimurium
Isolates from a monitoring
programme

Cattle
(bovine
animals)

Pigs

Gallus
(fowl)

Turkeys

Other animals
– Clinical
investigations

Number of isolates available
in the laboratory

8

0.6

2

2

0.6

Antimicrobials:

69

58

64

68

66

Tetracyclin

20

0

20

40

20

Florfenicol

30

20

30

60

50

Cefalexin

45

0

100

18

100

Neomycin

33

0

50

50

50

Trimethoprim + sulfonamides

43

43

43

43

0

(Source: Modified from EFSA, 2006a)
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In the western world the emergence of resistance to extended spectrum
cephalosporins is cause for concern.

Table 7b Antimicrobial susceptibility testing of Salmonella spp. in animals in the ROI
N = Number of resistant isolates
S. Typhimurium

Isolates out of a monitoring
programme

Cattle
(bovine
animals)

Pigs

Gallus
(fowl)

Turkeys

-

-

-

-

15

-

0

Number of isolates available 268
in the laboratory

Other animals
– Clinical
investigations

Other animals
– Clinical
investigations

Antimicrobials:

N

n

N

N

n

N

n

N

n

N

n

Tetracyclines Tetracyclin

220

20

15 12 -

-

0

0

13

3

2

1

Amphenicols Florfenicol

218

25

15 2

-

-

0

0

13

2

3

0

Cephalosporins Cefalexin

41

4

6

0

-

-

-

-

3

2

3

0

Fluoroquinolones
Enrofloxcin

221

2

15 0

-

-

-

-

13

0

3

0

Aminoglycosides
Streptomycin Neomycin

41

10

7

7

-

-

-

-

3

3

3

0

169

8

9

4

-

-

-

-

8

1

3

0

Trimethoprim +
sulfonamides Trimethoprim
+ Sulfonamide

223

12

15 10 -

-

-

13

1

3

0

Resistant to 1 anitmicrobial

-

26

-

3

-

-

-

-

-

-

-

1

Resistant to 2 anitmicrobials -

23

-

2

-

-

-

-

-

-

-

-

Resistant to 3 anitmicrobials -

7

-

3

-

-

-

-

-

2

-

-

Resistant to 4 antimicrobials -

1

-

2

-

-

-

-

-

1

-

-

Resistant to > 4
2
antimicrobials
(Source: Modified from Table P54, EFSA, 2006a)

4

-

-

-

-

-

1

-

-
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Antimicrobial resistance in Salmonella spp. in
Northern Ireland
Much of the recent NI-specific data is consolidated
into the Health Promotion Agency Reports (HPA,
2008) which have noted a generalised increase in
antibiotic resistance in Salmonella spp. isolates
from diseased animals, environment and feedstuffs. However, a recent survey of Salmonella
spp. isolated from post evisceration pig carcasses
and caecal contents, indicated a high incidence
of S. Typhimurium in caecal contents (19%) and
on carcasses (24%) (McDowell et al., 2007). The
majority of these were S. Typhimurium (DT104)
carrying the genomic island SgI1. McDowell et al.
(2007) reported high rates of resistance to these
antibiotics (>50%) but low or no resistance to other
clinically important antibiotics, such as, naladixic
acid (2.1%), ciprofloxacin (0%) and cefotaxime
(0%). The frequency of AMR in human enteric
salmonellae in NI is high. However, it is not as high
as reported in animal isolates for example, ACSSuT
(26- 27%) and nalidixic acid (16%) and much lower
for re ciprofloxacin and cefotaxime (< 1%) (Ong
et al., 2007). The increased level of resistance to
nalidixic acid (caused by single point mutation)
is of clinical importance (Stevenson et al., 2007).
The AMR profiles of Salmonella spp. differ among
food animal species. Porcine isolates tend to be
resistant to a greater number of antibiotics than
bovine or ovine, and turkey isolates are resistant
to a greater number of antibiotics than chicken
isolates (Table 7). No resistance to third generation
cephalosporins or ciprofloxacin have been
detected in any animal isolates, with the exception
of one case in poultry. This is an important as
ciprofloxacin is the drug of choice (DEFRA, 2006).
Such intra-species differences may reflect on the
intensity of the farming methods, for example,
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pigs are intensively reared indoors, where illness
in one animal is easily spread through the herd.
The whole herd may thus be treated, whereas
cattle or sheep are field farmed and are treated as
individual animals. The age of the infected animal
is also important. Salmonella spp. from calves
for instance, are significantly more resistant to
antibiotics than from older bovine animals (EFSA,
2006), although the reasons for this are unclear.
Evidence of food processing impacts
Increased thermotolerance in an MDR strain
of S. Typhimurium DT104 (in comparison with
antibiotic-susceptible strains of S. Typhimurium)
is of concern. Previous reports have speculated
on the mechanisms and implications of S.
Typhimurium DT104 possessing increased fitness/
survival characteristics, including thermal
tolerance, by overcompensation of fitness costs
or an increase in rpoS expression (EUCAST, 2000;
Humphrey, 2001). Walsh et al. (2001) reported no
difference in heat resistance between antibioticsusceptible and laboratory-acquired antibiotic
resistant (nalidixic acid and streptomycin) strains
of S. Enteritidis and S. Typhimurium at 55°C in
chicken meat. However, the same study reported
that MDR S. Typhimurium DT104 was significantly
more heat resistant at 55°C in chicken meat,
than the antibiotic-susceptible strains of S.
Typhimurium and S. Enteritidis. A subsequent,
larger study by Bacon et al. (2003a, 2003b) which
examined five MDR and five antibiotic-susceptible
strains including S. Typhimurium DT104 (at 55°C,
57°C, 59°C and 61°C in tryptic soy broth, with and
without glucose), reported no difference in heat
resistance between antibiotic-susceptible and
MDR Salmonella spp. isolates. When antibiotic
resistance is induced, some strain variations in

Verocytotoxigenic Escherichia coli (VTEC), in particular O157, are an important
cause of gastrointestial illness in the ROI.

acid resistance were observed, but no association
between antibiotic susceptibility and the ability
to survive low pH was made. Stopforth et al.
(2008) reported no difference in survival curves
between 10 MDR and 10 antibiotic-susceptible
isolates of Salmonella spp. As yet, there is no
conclusive evidence that acquisition of antibiotic
resistance confers resistance to food processing
stress in Salmonella spp. Available data suggests
that further experimentation is required.

VTEC – Pathogenic E. coli including
Introduction
Verocytotoxigenic Escherichia coli (VTEC), in
particular O157, are an important cause of
gastrointestial illness in the ROI (Epi-insight,
2008). They have emerged as significant
pathogens causing a range of severe (10%
of patients developing Haemolytic ureamic
syndrome (HUS)) and fatal illness. E. coli O157:H7
was the first E. coli serotype to be associated with
this distinctive illness. Additional verocytoxinproducing serogroups, frequently reported in the
ROI include, O26, O111, O103 and O145. Infection
can be transmitted through food, contaminated
water, the environment and by direct contact
with animals or humans.
Description of species
E. coli is arguably the best-known and most
intensely investigated group of the bacteria
found in humans and warm-blooded animals
(Park et al., 1999). It was first discovered by Dr.
Theodore Eschrich in 1885 (Neill, 1994). E. coli are
members of the Enterobacteriaceae family and
are characterised by being facultatively anaerobic
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Gram-negative rods, motile or non-motile,
chemorganotrophic and having both a respiratory
and a fermentative type of metabolism.
They are oxidase-negative, Vogues-Proskauer
negative, methyl red positive, catalase positive,
usually citrate negative and have an optimal
growth temperature of 37oC (Holt et al., 1994).
While E. coli are considered to play a role in the
maintenance of normal physiological function
(Neill, 1994), there are pathogenic strains that
cause diarrhoeal disease syndrome (Levine, 1987).
Such strains are categorised into the following
six groups based on virulence properties,
mechanisms of pathogenicity, clinical syndromes
and distinct O:H serogroups. Enteropathogenic
(EPEC), Enterotoxigenic (ETEC), Enteroinvasive
(EIEC), Diffuse adhering (DAEC), Enteroaggregative
(EaggEC) and Enterohaemorrhagic (EHEC) are
different types of E. coli strains (Doyle et al., 1997;
Sussman, 1997). EHEC are a defined subset of
VTEC, which are characterised by the presence of
verotoxins (shiga toxins). The term EHEC refers
to serotypes of E. coli that cause a clinical illness,
similar to that caused by E. coli O157:H7, which
produce one or more phage encoded shiga toxins,
possess a 60-megadalton virulence plasmid and
produce attaching-effacing lesions in an animal
model (Griffin and Tauxe, 2001).
VTEC in food on the island of Ireland
The presence of VTEC in food is of particular concern,
as the minimum infectious dose is estimated to
be as low as 10 viable cells. Two surveys carried out
in the ROI in 2006 and 2007, found none of the
retail products tested (238 and 573, respectively) to
contain E. coli O157 (see Table 8).
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Table 8 VTEC in food in the ROI
Food type

Tested for VTEC
2006

Positive 2006

Tested for VTEC
2007

Positive 2007

Bovine

9

0

8

0

Pork

2

0

0

0

Poultry

2

0

0

0

Sheep

1

0

1

0

Unspecified meat
and Other meat

24

0

0

0

Bovine

28

0

49

0

Pork

65

0

14

0

Poultry

14

0

11

0

Sheep

2

0

0

0

Unspecified meat
and Other meat

42

0

11

0

Milk and milk
products

8

0

13

0

Fish and fishery
Products

2

0

2

0

Fruit and
vegetables

5

0

3

0

Juice

0

0

172

0

Soft Drinks

0

0

275

0

Other food

34

0

14

0

Total

238

0

573

0

Fresh meat

Meat products

Other foods

(Source: FSAI, 2009)
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The ROI, England, NI, Scotland and Wales have some of the highest reported rates
of VTEC infection in Europe.

Other studies carried out on the ROI reported
that, 2.4 per cent of beef trimmings, three per
cent of beef carcass samples, one per cent of preand post-chill lamb carcass samples and 12 per
cent of milk filters, were positive for E. coli O157.
Cagney et al. (2004) reported that 2.7 per cent of
supermarket mince-meat samples and 3.14 per
cent of butcher shops mince-meat samples were
positive for E. coli O157 (Carney et al., 2006).

The ROI, England, NI, Scotland and Wales have
some of highest reported rates of infection in
Europe (European Food Safety Authority, 2005);
and in 2006, only Scotland (4.8 per 100,000) had
a higher incidence than the ROI. In the EU, 2,905
cases were reported in 2007 with an incidence of
0.6 cases/100,000 population (EFSA, 2009). Data
on serogroups was provided by 19 member states2,
and of these over half (54.1%) were serogroup O157.

Epidemiology of VTEC on the island of Ireland
and in Europe
In the ROI there were 115 confirmed and 521
probable cases of VTEC notified in 2007
(HPSC, 2007b). The crude incidence rate of 3.9
cases/100,000 population represents a six per
cent increase in the number of cases (n=158)
reported in 2006. This is the highest annual total
of VTEC infections ever reported in the ROI. Young
children suffered the highest burden of VTEC
with an age-specific rate of 17.5 cases/100,000
population, and all five HUS cases occurred in
children aged 1-7 years. Of the 115 confirmed
cases, the most common serotype reported was
O157 (n=94), followed by O26 (n=13). Two VTEC
cases were mixed infections: one VTEC O157 and
VTEC O103; the other VTEC O157 and VTEC O113.

A survey of Irish beef abattoirs carried out by
Whyte (2009) E.coli – its prevalence and virulence
in Irish beef, sheep and milk. Relay Final Report.
Available at: http://www.relayresearch.ie/
Public/p_research_project_details.asp?project_
id=271 revealed that O157 is the most prevalent of
five E. coli serotypes capable of causing human
illness. No E. coli O111 was detected in the survey
and despite the fact that O103, O145 and O26 were
found only a few of these were pathogenic. E. coli
O103, O26 and to a lesser extent O157 are quite
prevalent in Irish sheep populations. However,
only a very small proportion of isolates possess
the genes necessary to be highly pathogenic.
The risk associated with raw milk appears low.
This study highlights the need to establish the
virulence in addition to the prevalence of E. coli
so that more meaningful assessments of risk to
public health can be made.

In NI, 47 cases of laboratory-confirmed VTEC were
reported in 2006 with 17 cases in children aged
0-4 (CDSCNI).

2	Austria, Belgium, Denmark, Estonia, Finland, France, Germany,
Hungary, Ireland, Italy, Luxembourg, Malta, the Netherlands,
Poland, Slovakia, Slovenia, Spain, Sweden and the United
1
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The 52 probable cases were associated with a single outbreak

Kingdom
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Antimicrobial resistance in VTEC
To date, antibiotic resistance in VTEC has received
little research attention. This is mainly because
antibiotic therapy is not recommended in cases of
VTEC-associated infection and VTEC-strains have
been reported to be slower to acquire resistance
than generic E. coli strains (Mizan et al., 2002;
Sanchez et al., 2002; Bettelheim et al., 2003).
However, more recently, multi-resistant strains
of VTEC have been isolated from foods (Galland
et al., 2001; Schroeder et al., 2002a; Schroeder et
al., 2002b, Fitzgerald et al., 2003; Schroeder et
al., 2003), suggesting increasing proliferation of
antibiotic resistance among VTEC.
There is currently no surveillance data available
on antibiotic resistance in VTEC on the island of
Ireland, except for a few published studies in the
scientific literature. Walsh et al. (2006) compared
the antibiotic resistance profiles of E. coli O157:H7
isolates (n = 257) recovered from bovine hides,
mince-meat (ground beef) and human clinical
samples in the ROI to those profiles of a range of
Irish non-O157 E. coli (O111 and O26) isolates (n=31)
from a variety of clinical and veterinary sources
(Walsh et al., 2006). Four MDR E. coli O157:H7 food
isolates were identified, with resistance to 10 (one
isolate), six (one isolate) and four (two isolates)
antibiotics respectively. Another study by Murphy
et al. (2005) identified 16 antibiotic-susceptible
strains of VTEC from Irish bovine milk used in the
production of farmhouse cheese. One of these
isolates was resistant to streptomycin. Murphy et
al. (2007) also examined milk supplied (bovines,
ovines and caprines) to the Irish farmhouse
cheese sector and the manufacture of raw milk
ice cream. All of the E. coli O157:H7 isolates (n=19)
were susceptible to the panel of 15 antimicrobials
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tested and among the O26 isolates (n=17), three
were defined as MDR (ampicillin, tetracycline
and streptomycin). The prevalence of MDR is
considered to be low in VTEC isolates.
Even less information is available about antibiotic
resistance in E. coli O157:H7 in NI and the material
that is available is usually subsumed within UK
wide reports. Some information is available based
on veterinary and human clinical cases which
suggests that the incidence of antimicrobial
resistant E. coli O157:H7 remains very low in cattle
and sheep isolates, low in pig isolates, and with
the exception of tetracycline, very low in human
clinical isolates (see Table 9).

There is currently no surveillance data available on antibiotic resistance in VTEC on
the island of Ireland...

Table 9 AMR (%) in UK veterinary and human VTEC isolates. (Adapted from AMR, 2004).

Antibiotic

% of resistant isolates
Cattle

Sheep

Pig

Human

Ampicillin

1

0

8

2

Cefoperazone (cephalosporin)

0

0

0

0

Ciprofloxacin

0

Sulphonamide/trimethoprim

0

0

8

20

Tetracycline

6

0

46

18

Although antimicrobial resistance in E. coli
O157:H7 is low in most cases, the situation is very
different in non-VTEC E. coli, where the incidence
of resistance to antibiotics is high (>75%) or very
high (i.e. >90%) in some animal species, posing
the significant risk of transfer of (multiple)
resistance to E. coli O157:H7 by gene flow through
the resistome.
Evidence of food processing impacts
Food processing impacts are of concern when
dealing with low infectious dose pathogens,
such as, E. coli O157:H7, particularly with regard
to the processing of ready-to-eat foods, such
as, fermented meat. Only one study (Duffy et
al., 2006) has compared antibiotic-resistant and
antibiotic-sensitive VTEC under food-processing
stress. In this study, the impact of laboratory-
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acquired antibiotic resistance (to nalidixic acid
and streptomycin) on the growth and survival
of E. coli O157:H7 and E. coli O26 was examined.
The presence of antibiotic resistance did not
affect the growth kinetics (lag phases, growth
rates) of the VTEC strains, over a 24-hour period
at 37°C in laboratory media. The survival of the
VTEC antibiotic-resistant strains in orange juice
and yoghurt and their D-values at 55ºC were not
significantly different to the parent antibioticsensitive VTEC strains. However, another study
by McGee (2003) reported that acid sensitivity
occurred in one out of three antibiotic-resistant
(nalidixic acid and streptomycin) E. coli O157:H7
isolates. Duffy et al. (2006) also reported that the
growth kinetics, lag phases and growth rates of
an MDR E. coli O157:H7 (resistant to 10 antibiotics)
over 24-hour at 37°C in laboratory media were
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similar to all other strains tested (Duffy et al.,
2006). However, when subjected to food stresses
(acid and heat), this particular MDR E. coli O157:H7
isolate, was found to act very differently to the
unstressed antibiotic sensitive and antibioticresistant VTEC strains. All VTEC strains tested
were found to survive for approximately 30
days in orange juice at pH 4.4 and 25 days in
yoghurt at pH 4.2. The exception was the MDR
E. coli O157:H7 isolate which was found to have
died off significantly faster (P<0.05) in both
media, than in the other strains tested. Thermal
inactivation studies also showed the MDR strain
to be significantly more heat sensitive (D55 value
= 1.71 min) than all other VTEC strains examined in
this study, or indeed in the wider literature (11.13
to 139.2 min) (Juneja et al., 1998; Clavero et al.,
1998; Byrne et al., 2002; Huang and Juneja, 2003).
Thus, the acquisition of antibiotic resistance does
change resistance to other stresses by increasing
the AMR host sensitivity to environmental/food
processing related stress.
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Campylobacter is the most commonly reported cause of bacterial foodborne
infection on the island of Ireland.

Campylobacter
Antimicrobial resistance and virulence –
Campylobacter
Campylobacter is the most commonly reported
cause of bacterial foodborne infection on the
island of Ireland.
In the ROI in 2006, there were 1,815 notified cases
of campylobacteriosis, giving a crude incidence
rate of 42.8/100,000 population, a slight increase
from 42.5 from the previous year (HPSC, 2006).
The highest age-specific incidence rate was in
0-4-year-old children at >120/100,000. Of the 38
per cent of isolates with typing data, 91 per cent
were C. jejuni and eight per cent were C. coli. No
data were available on antimicrobial resistance.
In NI in 2006, there were 937 cases of laboratoryconfirmed campylobacteriosis and of those 106
were in 0-4-year-old children (CDSCNI).
There were 1,803 notified cases of
Campylobacteriosis in 2005 – over five times the
number of Salmonella spp. cases. Of the infectious
diseases caused by members of the Campylobacter
genus, Campylobacter gastroenteritis due to
Campylobacter jejuni and Campylobacter coli is the
only form of disease that is of major public health
importance (Oncul et al., 2003). Campylobacter is
a naturally transformable microorganism (Wang
and Taylor, 1990) that is capable of acquiring a
diverse array of Gram-positive (Werner et al., 2001)
and Gram-negative (Pinto-Alphandary et al., 1990)
AMR genes. Increasing antimicrobial resistance in
both medicine and agriculture in Campylobacter
is recognised by various national authorities, such
as, the Food Safety Authority of Ireland, and global
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authorities such as the WHO as a major emerging
public health concern (Moore et al., 2006).
Campylobacter may be transmitted to humans
either directly or indirectly. Direct transmission
can occur via contact with animals, carcasses
or water which has been infected. Indirect
transmission can occur through the ingestion
of contaminated food or water. In the US, the
highest risk factor for campylobateriosis is the
consumption of commercially-prepared chicken
(Rocourt et al., 2003).
In an all island study, Campylobacter was isolated
most frequently from retail poultry (chicken
49.9%, turkey 37.5% and duck 45.8%) (Whyte et
al., 2004). However, data from the EU in 2005
showed that the incidence of Campylobacter spp.
in fresh poultry meat at slaughter ranged very
considerably from 4.6 per cent to 56.1 per cent.
Similarly, at processing, the incidences ranged
from 3.8 per cent to 51.9 per cent and at retail
between 3.1 per cent and 66.4 per cent. Livestock
production, in particular poultry production, has
become very intensive across the island of Ireland
during the last 20-30 years. Research has shown
that by the third or fourth week of production,
most poultry flocks are contaminated to some
extent with Campylobacter spp., resulting in the
eventual spread of the organism to almost all
members of the flock. In the above all Ireland
study (Whyte et al., 2004), Campylobacter was
also isolated from beef (3.2%), pork (5.1%) and
lamb (11.8%) and fresh mushrooms (0.9%). A
number of more recent UK/NI/EU studies have
reported Campylobacter isolation rates of 63 per
cent (DEFRA, 2006), 98.3% (EFSA, 2010) and 86.2
per cent (Meldrum and Wilson, 2007) from poultry.
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Recent isolation rates include raw meat (4.8%),
pork (2%), lamb (8.5%) and raw milk (1.9%). Madden
et al. (2007) noted 24.8 per cent incidence in NI
beef cattle faeces, suggesting a potential source
for carcass contamination, although the incidence
of Campylobacter on NI beef cattle carcasses is very
low (Madden et al., 2001).
AMR is a common feature of Campylobacter
isolated from food of animal and nonanimal origin. In a European study in 2006,
Campylobacter isolates from poultry meat
were found to have a high level of resistance to
ciprofloxacin (30.6%) (Piddock, 2006). Resistance
to this antibiotic was also high in isolates from
fowl (Gallus gallus), pigs, cattle, at levels of 31.6
per cent to 56.7 per cent. In addition, resistance
to tetracycline was found to be very common
(EFSA, 2006). In food animals, the prevalence of
resistance to erythromycin is generally higher in
C. coli, in particular in C. coli isolates from pigs,
than in C. jejuni (Engberg et al., 2001). In Spain,
it was found that the rates of erythromycin and
quinolone resistance in C. coli from pigs were 81
per cent and 100 per cent, respectively (Saenz et
al., 2000). Antibiotics used in high concentrations
in animal feed can be found in animal manure,
which can end up as plant fertiliser (Kühn et al.,
2003). In the US, poultry litter is spread on fields
as a fertiliser which can be a source of MDR
bacteria (Gangle, 2005). This has been shown
in vitro by Batchelder and colleagues in 1981
(Batchelder, 1982).

64

Information on the AMR profiles of Campylobacter
spp isolated from animal/food sources in NI/
UK is generally regarded as weak, with the last
UK survey of AMR in Campylobacter spp isolated
from animals (carried out on pigs only) in
2003. Although, there appears to be a trend of
increasing resistance to quinolones (ciprofloxacin)
and macrolides (erythromycin, Table 10), there
is little updated data available to confirm this
suggestion (Rao et al., 2005). The majority of data
originates from poultry isolates, and as such may
not be representative of all food animal isolates.
It has been reported that a high proportion
of animal Campylobacter spp are resistant to
ampicillin/tetracycline (>40%) and ciprofloxacin/
nalidixic acid (>20%). A recent report stated that
22 per cent of chicken isolates have multiple
AMR (resistant to three antibiotics or more), a
significant advance from the report of Randall
et al. (2003) which suggested that 3.8 per cent of
Campylobacter spp from combined human and
animal origins were multi-resistant. It is not clear
if this increased MAMR is matched in other food
species, especially as wide variations have been
reported in the AMR profiles of Campylobacter
isolates from different types of retail meats. In
general, Campylobacter spp isolated from pork
and poultry have higher and broader resistance
to antibiotics than lamb or beef. This may be
attributable to the intensive farming methods
used in pig and poultry rearing, where mass
medication is relatively common and high
stocking levels may facilitate dissemination of
pathogens and AMR genes between animals
(Turnidge, 2004; McGill et al., 2006).

A high proportion of animal Campylobacter spp are resistant to ampicillin/
tetracycline and ciprofloxacin/nalidixic acid.

On the island of Ireland, a high degree of
similarity between the AMR/MAMR profiles of
clinical and food Campylobacter spp isolates
has been reported (McGill et al., 2006), along
with increased resistance to clinically relevant
antibiotics, such as, ciprofloxacin, erythromycin
and tetracycline among food isolates. In NI,
Rao et al. (2005) reported concurrent increases
in erythromycin resistance in C. jejuni isolates
from humans and from poultry during the period
1999-2003, although susceptibility to other
antibiotics (penicillin, cefalexin, chloramphenicol,
ciprofloxacin and tetracycline) remained static
over this period. The above noted increase in
erythromycin resistance is of clinical significance.
The above data suggests that Campylobacter spp
isolated from animal/food and those isolated
from human campylobacteriosis may be linked
via the food chain (Rao et al., 2005, McGill et al.,
2006), although GE et al. (2002) noted significant
delays between peaks of isolation. There is,
however, a reported lack of temporal association
between human infections and contamination in
retail chicken products, particularly during peak
seasons (Wilson, 2002). This may simply be due
to the incubation period for campylobacteriosis
infection of up to 10 days combined with the time
taken for isolation, identification and reporting
of the condition to the relevant public health
authorities, which can be up to two weeks. The
data made available in the report by Wilson
(2002) indicates that a peak in Campylobacter spp.
isolation from raw chicken is often followed 4-5
weeks later by a peak in isolation from humans.
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Table 10 AMR profiles of Campylobacter spp in NI.
% isolates resistant
Clinical 2001/2* Poultry meat
(C. jejuni)
2001/2*
(C. jejuni)

Other retail
food products
2001/2*
(C. jejuni)

Pig meat
2002**
(campy spp)

Poultry meat
2004**
(C. jejuni)

Amp

17

24

32

21

64

CHl

4.1

7.8

9

0

5

Cip

13

18

14

21

21

Ery

6.2

5.2

18

55

3

Nal

17

18

0

25

23

Tet

10

12

18

69

41

Data from
* (McGill et al. 2006)
**AMR report 2004
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There are examples from many countries where fluoroquinolone-resistance rates are
similar in isolates from poultry products and humans...

Fortunately, most cases of human Campylobacter
enteritis do not require antimicrobial treatment,
as the symptoms are usually clinically mild, and
self-limiting in healthy adults (Casburn-Jones and
Farthing, 2004). A survey conducted in the ROI in
2003 found that only 7.4 per cent of those with acute
gastroenteritis reported were taking antibiotics
(Igoe et al., 2003). However the symptoms of
campylobacteriosis can vary from mild self-limiting
enterocolitis lasting 24 hours to more severe
illness including diarrhoea, abdominal cramps and
vomiting which can last up to 10 days. For those
immunosuppressed or with chronic intestinal
disorders, Campylobacter infection can have more
serious consequences and long-term antibiotic
therapy may be necessary (McGill et al., 2006). The
use of Quinolones (ciprofloxacin) is considered to
be the first choice for treatment as they are also
considered useful for the prophylaxis of travellers’
diarrhoea (Ericsson, 2003; Piddock, 2006). This
approach was adopted because the symptoms of
Campylobacter enteritis essentially mimic those of
bacterial gastroenteritis caused by other enteric
pathogens, such as, Salmonella spp. and Shigella spp.
Furthermore, the susceptibility of these pathogens
to fluoroquinolones, empirical treatment for severe
gastroenteritis with these drugs was used before
culture tests were confirmed (Alfredson and Korolik,
2007). In 1991, Endtz et al. reported quinolone
resistant C. jejuni and C. coli isolated from humans
were emerging in The Netherlands (Endtz et al., 2002).
Patients infected with fluoroquinolone resistant C.
jejuni tend to have longer duration of diarrhoea than
patients with fluoroquinolone-sensitive isolates
(Phillips et al., 2004). Thus, macrolides (erythromycin)
became the most commonly used agent for
treatment of C. enteritis (Engberg et al., 2001).
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It is interesting to note that the resistance of C. jejuni
and C. coli isolates from humans in The Netherlands
coincided with the introduction of fluoroquinolones
in veterinary medicine in a number of countries
(Aarestrup et al., 1998; specifically in poultry (Endtz et
al., 2002). Recognition of this relationship led to bans
in the veterinary use of such products, for example,
sarafloxacin was withdrawn from use during 2001
(Gupta et al., 2004), and in 2005, the Food and
Drug Association banned the use of enrofloxacin,
previously used in the treatment of colibacillosis in
chickens and turkeys (Higgins et al., 2007).
There are examples from many countries where
fluoroquinolone-resistance rates are similar in
isolates from poultry products and humans (Endtz et
al., 1990; Wegener, 1999; Saenz et al., 2000). In the UK,
enrofloxacin was first licensed in late 1993. Previously,
domestically-bred chickens were less frequently
infected with quinolone-resistant Campylobacter
than imported chicken products. Researchers found
a correlation between the percentage of human
isolates with antibiotics resistance and estimates
of the amount of imported chicken consumed in
the UK (Payne et al. 2002). In recent data from Spain
and Taiwan, rates of erythromycin resistance were 17
per cent for both countries in C. jejuni isolated from
foods, whereas for C. coli the rates were 50 per cent
and 83 per cent, respectively (Li et al., 1998; Saenz
et al., 2000). Macrolides, the current treatment of
choice for campylobacteriosis, have been banned for
use as a growth promoter in the EU since July 1999
(Casewell et al., 2003). However, the high incidence
of resistance to erythromycin in C. coli isolates from
pigs has been related to extensive veterinary use of
macrolides (Gibreel and Taylor, 2006; Kim et al., 2006)
during pig production.
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Evidence of food processing impacts
Since consumption of poultry is one of the major
risk factors in acquiring campylobacteriosis
it is worth considering the impact of poultry
processing on antibiotic resistance of this
pathogen. Slaughter and processing provide
opportunities for reducing C. jejuni counts on
food-animal carcasses. Bacterial counts on
carcasses can increase during slaughter and
processing steps. In one study, up to a 1,000fold increase in bacterial counts on carcasses
was reported during transportation to slaughter
(Stern et al., 1995). Research studies carried out
on chickens (Izat et al., 1988) and turkeys (Acuff
et al., 1986) at slaughter, found that bacterial
counts increased by approximately 10-to-100
fold during defeathering with the highest level
found after evisceration. However, bacterial
counts on carcasses declined during other
slaughter and processing steps. For instance,
Oosterom et al. (1983) reported that forced-air
chilling of swine carcasses caused a 100-fold
reduction in carcass contamination. In Texas, in
turkey plants, scalding reduced carcass counts
to near or below detectable levels (Acuff et al.,
1986) and the addition of sodium chloride or
trisodium phosphate to the chilled water in the
presence of an electrical current reduced C. jejuni
contamination of chilled water by two log10 units
(Li et al., 1995). In a slaughter plant in England, the
use of chlorinated sprays and the maintenance
of clean working surfaces resulted in a 10-to-100
fold decrease in carcass contamination (Mead et
al., 1995). In another study, lactic acid spraying
of swine carcasses reduced counts by at least
50 per cent to undetectable levels (Epling et al.,
1993). Furthermore, a radiation dose of 2.5 KGy
reduced C. jejuni levels in retail poultry by 10 log10
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units (Patterson, 1995). Freezing or chilling of
poultry meat has been shown to greatly reduce
the number of live Campylobacter present on
the product. In addition, it is thought that the
aeration resulting from preparation of ground
meat products helps reduce the number of
viable cells of Campylobacter, as this organism is
sensitive to high oxygen tension.
During the slaughter of cattle and swine, fresh
carcasses are cooled by forced air ventilation. This
treatment both temporarily freezes and dries the
surface, and this process has been documented to
effectively reduce the number of Campylobacter
cells on the surface of the carcass (Chang et al.,
2003). Red or white meat undergoing any heat
treatment or freezing during processing will
harbour less Campylobacter than meat produced
without such treatment. Furthermore, meat
which is dried, cured, salted, smoked, irradiated
or exposed to other preservation methods,
will also harbour less Campylobacter compared
to the unpreserved product. The capacity of
different treatment processes to affect the
microbiological status of meat products is an
area of intense interest. However, public demand
for fresh poultry meat (e.g. cuts of breast meat),
over whole frozen carcasses has contributed
significantly to the decade-long increase in the
incidence of human Campylobacter observed in
many industrialised countries.

...when resistance emerges in Campylobacter in animals, resistant Campylobacter
can be transmitted to humans.

There are no significant biological reasons why
resistant Campylobacter should not transmit
equally well from animals to humans, as does
sensitive Campylobacter. Hypothetically, there
may be a small fitness loss when a strain of
Campylobacter mutates and becomes resistant
to quinolones, however, this loss of fitness may
be compensated in successive generations.
Thus, when resistance emerges in Campylobacter
in animals, resistant Campylobacter can be
transmitted to humans. In addition, results
of a recent study have indicated that certain
strains gain increased fitness when acquiring
fluoroquinolone resistance mutations (Luo et al.,
2005). This process is undesirable as it suggests
that the acquisition of AMR can lead indirectly
to the emergence of more widely generally,
competitive AMR strains. Doyle and Erickson
(2006) noted such effects as examples of the
complex nature of antibiotic resistance and the
large data gaps that exist in making informed
scientific decisions on the use of antimicrobials in
animals used as food.
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Methicillin-resistant Staphylococcus
aureus (MRSA)
Emerging/new pathogenic bacterial hazards
Staphylococcal food poisoning occurs after
the ingestion of food contaminated with the
staphylococcal enterotoxin(s) (A, B, C1, C2, C3, D,
E, G, H, I, J, K, L, M, N and O) (Smyth et al., 2006).
It is mainly caused by human strains of S. aureus
producing SE(A) and/or SE(D), with the majority
of strains producing SE(A) alone. The amount
of toxin necessary to cause illness depends
on the susceptibility of the person. However,
epidemiological studies have shown that only
one μg of SE toxin can cause food poisoning. It
should be noted that, to produce this amount
of SE, an entertoxigenic strain needs to grow
to levels of 105 to 106 cells per gram or ml. The
onset of food poisoning symptoms usually occurs
between one and seven hours after the ingestion
of food containing SE. Symptoms include nausea,
vomiting, abdominal cramps and diarrhoea. In
severe cases, fainting may occur. Recovery is
usually rapid, i.e. within two days.
Outbreaks and sporadic cases of staphylococcal
food poisoning have been linked with foods
such as, cheese, salami, bakery products, pasta,
canned meat, canned fish and canned vegetable
products. In relation to cheese, failure of the
starter culture may provide an opportunity for S.
aureus to grow and produce SE. Staphylococcal
food-borne disease has been reported as
the second most common cause of reported
foodborne illness in the US (Halpin-Dohnalek
and Marth, 1989). In the EU, 164 outbreaks
were attributed to Staphylococcus spp. in 2005
(European Food Safety Authority, 2006). This

70

represented 3.1 per cent of all outbreaks reported.
In 2004, only three cases of staphylococcal food
poisoning were reported, in 2005 there were six
cases and in both 2006 and 2007, no cases were
reported in the ROI, however it is thought that
this illness is under-report because the symptoms
are generally not severe enough for the patient to
visit their General Practitioners (Health Protection
Surveillance Centre, 2004). Furthermore, because
staphylococcal food poisoning is toxin mediated
and generally self-limited, antibiotics are not used
for the treatment of this illness (Gill and Hamer,
2001).
MRSA is generally regarded as a health-careacquired, or increasingly, a community-acquired
pathogen. Notably, MRSA was not reported as a
cause of outbreaks of gastroenteritis until 2002 in
the US. The reason is that many S. aureus isolates
obtained as part of outbreak investigations may
not be tested for antibiotic susceptibility – and,
therefore, Methicillin-Resistant Strains (MRS)
may go unrecognised as the cause of foodborne
outbreaks of acute gastroenteritis. MRSA are as
likely to produce enterotoxins as are methicillinsensitive strains (Jones et al., 2002).

...infection of humans by transmission through food products contaminated with
animal MRSA may occur.

In 2002, a reported outbreak in the US, found
that MRSA contaminated food was the vehicle in
a cluster of illnesses affecting low-risk persons
within the community. This food was probably
contaminated by an asymptomatic carrier whose
only apparent exposures were intermittent
visits to a nursing home (Jones et al., 2002).
This outbreak could be an example of secondgeneration spread of a health-care-associated
pathogen into the community. While antibioticresistant strains are not expected to be clinically
more virulent or challenging in the setting of
acute outbreaks of gastroenteritis, MRSA may
cause soft-tissue and other infections in the
community that are difficult to treat.
In the 1990’s an MRSA outbreak causing 21
cases of septicaemia and five deaths occurred
in the University Hospital Rotterdam, in The
Netherlands. The initial reservoir for the outbreak
strain was probably a dietary worker, who carried
MRSA in his throat and prepared food for patients
on the haematology unit. Transmission of MRSA
by contaminated food had not been described
before this outbreak (Kluytmans et al., 1995).
A study carried out in Korea from May 2001 to
April 2003, found that, out of a total of 1,913
specimens from cattle, pigs, and chickens,
421 specimens contained S. aureus. Of the
421 specimens, 15 were mecA-positive MRSA
isolates; twelve were obtained from dairy
cows and three from chickens. The genomes
of the six animal MRSA isolates, were very
closely related to those of some human MRSA
isolates and were a possible source of human
infections caused by consuming contaminated
food products made from these animals (Lee,
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2003). These results suggested that infection of
humans by transmission through food products
contaminated with animal MRSA may occur.
More recently, a number of reports have reflected
increasing concerns in this area (Kitai et al., 2004;
Lee et al., 2003) especially considering ongoing
increases in resistance to antibiotics which are
typically part of MRSA’s resistant profile. Within
the last year, MRSA has been reported in pigs,
chickens and cattle in a number of European
countries, but this organism is not yet included in
UK/ROI food surveillance reports.
While Staph aureus food poisoning is toxinmediated and so the impact of MRSA food
poisoning may not be more severe than
susceptible SA, the use of antimicrobials in food
animals poses a threat to public health through
the introduction of new sources of MRSA into
the human population. In The Netherlands, it
has been demonstrated that pig farmers have a
760-fold increase in carriage of MRSA over the
general population, and there is evidence that the
source of the MRSA is the pigs which have been
exposed to antimicrobials. Hence, pig farmers
are at a greater risk of exposing MRSA to their
contacts, which in turn may affect the wider
community. This source of MRSA threatens the
highly successful efforts in The Netherlands to
control MRSA in healthcare facilities.
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Clostridium difficile
Clostridium difficile is not currently considered
a foodborne pathogen and is usually found
in the human large intestine (bowel). It is the
most common cause of diarrhoea following
antibiotic therapy and almost all patients who
develop C. difficile diarrhoea are taking, or have
recently been prescribed antibiotic therapy. A
small proportion (less than one in 20) of the
healthy adult population carry a small amount of
C. difficile, but it is kept in check by the normal
bacterial population of the intestine. C. difficile
can also form spores which allow it to survive
in the environment outside the body. These
spores protect it against heat and chemical
disinfectants. Most infections are reported from
hospitals and nursing homes, but can also occur
in the community.
In most cases, C. difficile causes a relatively mild
illness. However, infection may result in serious
illness and even fatalities in patients of advanced
age, and/or suffering from a serious underlying
illness, or with conditions that compromise the
immune system (e.g. cancer). In addition, patients
who have recently had gastrointestinal surgery or
those who have spent a long time in hospital or
other healthcare setting are also at risk.
C. difficile infection is generally not associated
with individuals whose immune system is not
already compromised. People can become
infected if they touch items or surfaces that
are contaminated with faeces and then touch
their mouth or mucous membranes. Healthcare
workers can spread the bacteria to other patients
or contaminate surfaces through hand contact.
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The ability of C. difficile to form spores allows it
to survive for long periods in the environment
(including areas around the patient’s bed, the
toilet areas, sluices, commodes, bed pan washers,
on floors etc). Apart from the above principal
symptom (diarrhoea), C. difficile infection is also
associated with fever, loss of appetite, nausea
and abdominal pain/tenderness. Generally,
C. difficile takes advantage of the disruption
of the normal, healthy intestinal bacteria by
antimicrobial therapy. When C. difficile is not
challenged by the normal bacterial gut flora, it
multiplies in the gut and produces toxins that
damage the cells lining the intestine, resulting in
violent and profuse diarrhoea.
The presence of these organisms is normally
detected by an Enzyme-linked Immunosorbant
Assay (ELISA) assay binding C. difficile toxin,
a process that does not differentiate among
the 100 strains of C. difficile which have so far
been identified. Recently, C. difficile Type O27
(first identified in the UK in 1999) has been
demonstrated as the predominant strain in two
outbreaks in the UK in 2004-2005. This strain
was previously associated with a large severe
outbreak in hospitals in Canada (Quebec) and
North-Eastern USA commencing in 2000. Cases
of infection with strain type O27 have been
reported in other European countries, including
the ROI (Epi-insight, 2006a). Early reports suggest
that this strain is more virulent, since it produces
a higher amount of toxin, than other ribotypes
examined to-date. The production of high
amounts of toxin in this ribotype, is the result of
a deletion in the gene which normally restricts
toxin production. C. difficile Type O27 is believed
to cause a greater proportion of severe disease,

...published data comparing human and animal isolates revealed the presence of
C. difficile in food.

and to have a higher rate of mortality. This is not
helped by the ease of transfer of C. difficile O27
and infection between patients or its increasing
resistance to fluoroquinolones. Resistance to
fluoroquinolones and administration of these
antibiotics has emerged as an important risk
factor for C. difficile associated diarrhoea in an
epidemic in Quebec.
Recently published data comparing human
and animal isolates revealed the presence of C.
difficile in food. This finding strongly suggests
that transmission from food animal reservoirs
is a possible source for community-associated
infections (Rupnik, 2007). C. difficile-associated
disease or asymptomatic carriage has been
described in animal species (Songer and
Anderson, 2006), but the C. difficile types in the
human and the animal populations have not
been compared in detail. If animals are indeed
a potential source of C. difficile infection, food
could be one of the transmission routes from
animals to humans. Approximately 20 per cent
of retail ground meat samples or other retail
meat products have been shown to contain C.
difficile (Rodriguez-Palacios et al., 2007) and at
least some of the ribotypes found in meat (O77,
O14, M26, M31) have been recovered from dogs,
calves and humans. Type M26 is identical in a
number of molecular characteristics (toxinotype
III, 18-bp deletion in tcdC, presence of binary toxin)
to type O27, and was also found to be resistant
to levofloxacin and clindamycin. However, the
ribotyping and pulsed-field gel electrophoresis
profiles of Type M23 are only 80 per cent similar
to O27 strains from humans. C. difficile could
contaminate meat during processing, but another
possibility is that spores are already present in
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the muscle tissue. The latter possibility has been
described for other clostridial species in horses,
but not for C. difficile (Vengust et al., 2003).
Whether antibiotic resistant strains of C. difficile
are affected differently by processing compared
to non-antibiotic-resistant strains remains to
be determined, but further evaluation is still
required on the exact role of food as a route of
transmission of this micro-organism.
A marked increase in Clostridium difficile
Associated Disease (CDAD) has been reported
across Europe and North America over the past
decade or so, and for the EU alone, the potential
cost of CDAD has been estimated as three billion
euro annually (Kuijper et al., 2006). Kuijper et al.
(2006) noted that CDAD is an increasing threat to
human health, with multiple issues of concern,
including an increase in the elderly and vulnerable
population in Europe, and an increase in reports
of resistant and more virulent strains of C. difficile
and C. difficile strains that are more difficult
eliminate from the environment due to resistance
to many cleaning agents (Kuijper et al., 2006). The
control of C. difficile is an important challenge in
human healthcare and it is essential that no new
source from animal reservoirs is allowed to occur.
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Commensal non-pathogenic
bacterial hazards
Commensals may play a role in the spread of
antibiotic resistance, through the dissemination
of resistance genes to susceptible bacteria. In
humans and animals this is most likely to occur in
the intestinal tract, where the ability of bacteria
to colonize, transfer and accept resistance
determinants remains important. A knowledge gap
exists on the prevalence of antibiotic resistance
genes in the animal and human intestines. The two
most studied bacteria of the gastrointestinal tract
(Enterococci and E. coli) make up only one per cent
of the total intestinal microflora. The majority of
intestinal bacteria cannot be cultivated, and much
of the limited knowledge that exists, is about
the minority, cultivatable (potentially atypical)
populations (EFSA, 2008).
The application of culture-free and genomicallybased forms of detection and differentiation
to these complex populations is likely to make
considerable contributions to our understanding of
the interactions of such commensals with enteric
pathogens. This in turn should clarify the relative
significance of the presence of antibiotic genes in
commensals in the acquisition and dissemination
of these genes in zoonotic/enteric pathogens.
However, it is also important to note that many
of the commensals which are amenable to
current analytical methods have already been
shown to carry qualitatively and quantitatively
significant complements of antibiotic-resistant
genes. For example, in recent times there have
been significant increases in the percentage of
vancomycin-resistant Enterococcus faecium (37.1%)
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and ciprofloxacin-resistant E. coli in the ROI, while
the proportion of MRSA has remained stable,
albeit high, at approximately 42 per cent for the
past four years (Epi-Insight, 2006b).
Enterococcus spp
Enterococci are Gram positive, facultative
bacteria with low intrinsic virulence. They are
natural inhabitants of humans and animals and
are occasional opportunistic pathogens of the
urinary tract, bloodstream, intra-abdominal
and pelvic regions, surgical sites and the central
nervous system (Murray and Weinstock, 1999).
Enterococcus faecalis are responsible for 8090 per cent of human enterococcal infections
(Jones et al., 2004) and Enterococcus faecium is
generally responsible for the remainder. Both
species are reported to be intrinsically resistant
to cephalosporins, low concentrations of
aminoglycosides, clindamycin, fluoroquinolones
and trimethoprim-sulfamethoxazole. In
addition, many strains harbour transmissible
genetic elements for acquired resistance to
tetracycline, erythromycin and chloramphenicol
and most importantly glycopeptide antibiotics
(vancomycin, teicoplanin). The mechanism
of vancomycin and teicoplanin resistance
in Enterococci is based on the presence of a
particular type of peptidoglycan precursor
terminating in D-Ala-D-lactate instead of D-AlaD-Ala, the normal binding site of glycopeptides
(Bugg et al., 1991). The key enzymes involved are
specific ligases VanA or the less common ligase
VanB. The gene cluster coding for resistance
contains four or five other genes in addition to
the ligase. The additional genes which contribute
to the phenotype include; vanR, vanS, vanH, vanX
or vanZ. This gene cluster is often associated

In 1996, there were 265 reports of E. faeclum bacteraemia in the ROI, of which 37.1
per cent were vancomycin resistant.

with a transposon (Tn1546), highlighting the
potential for resistance transfer (Arthur and
Courvalin, 1993). Other clinically important
resistance types include vanC, vanD and vanE type
ligases (Cetinkaya et al., 2000). During the past
two decades, the incidence of hospital-acquired
infections has risen and these are increasingly
associated with MDR (Linden et al., 2007). While
vancomycin resistance may compromise the
treatment of nosocomial infections, there is
concern for the eventual transfer of vancomycin
resistance to MRSA and the serious consequences
that this might entail.
Antimicrobial resistance in
Enterococcus faecalis
In 1996, there were 294 reports of E. faecalis
bacteraemia in the ROI, of which 3.7 per cent
were vancomycin–resistant isolates. While this
percentage may seem low, the ROI has one of the
highest proportions of vancomycin–resistant E.
faecalis in Europe (Epi-Insight, 2007b)
Antimicrobial resistance in
Enterococcus faecium
In 1996, there were also 265 reports of E.
faecium bacteraemia, of which 37.1 per cent
were vancomycin resistant, the proportion of
vancomycin resistant isolates had increased by
6.4 per cent per year. Of the 265 strains isolated,
25.6 per cent were found to be MDR, showing
an increase of six per cent per year, reported
between 1991 and 1996 (Epi-insight, 2007b).
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Foods associated with Enterococci
Enterococci are widely distributed in the
environment, human and animal gastrointestinal
tracts, and are frequently isolated from raw
milk, meat, vegetables, or any food that comes
in contact with soil or surface water. However,
their presence in food products is not always
correlated with faecal contamination, making
them inefficient hygiene indicators in food
processing plants (Birollo et al., 2001). The
ability of this species to survive pasteurisation
temperatures and grow under a wide range of
adverse conditions (high and low temperatures,
pH and salinity) enables them to persist in
processed food products. Enterococci are also
associated with fermented foods, (such as,
cheeses and meats) and are widely used as starter
cultures in the food industry.
Evidence of food processing impacts
There is currently no literature available on any
differential effects of food processing stresses
on antibiotic-susceptible and antibiotic-resistant
Enterococci. However, there is evidence that
conditions within the food-chain may assist in
the dissemination of resistant genes, for example,
there are reports that the vanA gene has been
transferred in vivo from chicken isolates to human
strains (Lester et al., 2006). This worrying report
highlights the real potential for the transfer of
antibiotic resistance from animal/food isolates
to human isolates within the food chain, and
underlines the need for further investigation
of the factors controlling or stimulating such
transfers, especially when one considers the
types and incidences of AMR involved.
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Non-pathogenic E. coli
Description of Species
Previously described see pathogenic E. coli
including VTEC (Section 4).
Antimicrobial resistance in E. coli
In the ROI in 2006, 21.5 per cent of E. coli were
resistant to drug ciprofloxacin, a fluroquinolone
drug. This has increased significantly from 5.4
per cent in 2002, at a rate of approximately four
per cent increase per year. In wider terms, E. coli
have also been found to be resistant to ampicillin
(70.7%), third generation cephalosporin’s (4.2%),
aminogycosides (7.7%) and Extended Spectrum
ß-Lactamases (ESBL) (20.8%). The above levels of
fluoroquinolone-resistance incidence are higher
than in the rest of Europe, while the levels of
cephalosporin and aminoglycoside resistance are
lower. On a positive note, no significant increase
in ESBL-producing bacteria has been observed in
the ROI in recent years. Overall, nine per cent of
E. coli tested in 2006 were reported to be MDR
resistant. This is in contrast to 2.4 per cent in
2002, an increase of approximately 1.7 per cent per
year (Epi-Insight, 2007b).
Food associated with E. coli
Food products particularly associated with
outbreaks of E. coli food poisoning include; raw
ground meat, fermented meat, raw unwashed
fruits and vegetables (in particular spinach and
sprouts), raw milk, unpasteurised juice,or foods
contaminated by infected food workers via
faecal-oral route. (For further information see
verocytotoxigenic E. coli).

Evidence of food processing impacts
Evidence of the impact of food processing on
antibiotic resistant E. coli has been previously
discussed in the section on non-pathogenic VTEC.
No information is available on the impact of food
processing stresses on ABR in commensal E. coli.

Probiotics added to food
Bacteria have been added to foods for a long time,
and their application in the production, flavour and
texture modification of a diverse range of food
items remains a very important activity of the food
industry. For example, bacterially-cultured dairy
products remain the driving force in the growth of
dairy food consumption with generated retail sales
close to $4.8 million (a3.8 million3; £3.4 million)
in 2005 (Cogan et al., 2007). Lactic acid bacteria
(LAB) play a vital role in the manufacturing, flavour,
texture and the development of fermented dairy
foods. These include lactobacilli, lactococci,
streptococci, enterococci, pediococci and
leuconostocs. More recently the health benefits of
these bacteria have been studied, with LAB such
as, lactobacilli, enterococci or Bifidobacteria spp.
being used in the production of probiotic products.
Most food-associated LAB have ‘Generally
Regarded As Safe’ (GRAS) status, since there
have been no reports of clinical cases associated

3

Currency exchange rate = $1USD is equivalent
to 0.7920 euro and 0.7016 pound sterling
(accessed 17th February, 2009)
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In the ROI in 2006, 21.5 per cent of E. coli were resistant to drug ciprofloxacin...

with industrial starter strains. A few clinical
cases associated with probiotic Lactobacillus
rhamnosus have been reported (Rautio et al.,
1999; de Groote et al., 2005), however these
incidences are quite isolated given the extensive
use of LAB. This suggests that the chances of
bacterial infection associated with LAB are
remote, and that the presence of antibioticresistance genes in LAB does not present any
significant, direct challenges to clinical medicine.
However, there are now increasing concerns
that antibiotic resistant genes present in nonpathogenic bacteria (like LAB) can be transferred
to pathogenic strains. The fact is that many
fermented dairy products and meats that are not
heat-treated before consumption may provide
a vehicle for antibiotic-resistant bacteria with
a direct link between the animal indigenous
microflora and the human gastrointestinal tract
(Mathur and Singh, 2005).
Few comprehensive studies exist on antibiotic
resistance in LAB of food origin, in particular
lactococci and lactobacilli. Research has
mainly focused on the opportunistic pathogen
Enterococci. Since Enterococci have been previously
discussed in this report, current antibioticresistant genes are listed for non-enterococcal
LAB and Bifidobacteria spp. (Table 11).
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Table 11 AMR genes in non-enterococcal LAB and Bifidobacteria spp. (Modified from Ammor et al., 2007)

Species/Strain name

Resistance Gene(s)

Strain Origin

Bifidobacterium longum

tet(W)

Animal, Human

tet(M)

Human

Bifidobacterium spp.

tet(W)

Animal, Human, Probiotics

Lactobacillus acidophilus

aaa(6’)Ie-aph(2”)Ia

Animal

tet(M), erm(B)

Dairy produce, Human

Lactobacillus alimentarius

tet(M)

Fermented Dry sausage

Lactobacillus animalis

erm(B)

Animal

Lactobacillus casei

tet(M), erm(B)

Dairy produce, Human

Lactobacillus crispatus

erm(B)

Animal, Human

tet(M)

Human

Lactobacillus curvatus

tet(M)

Fermented dry sausage

Lactobacillus fermentarium

tet(M), erm(B)

Human

erm(LF), vat(E-1), tet(M)

Dairy produce

erm(B)

Animal

Lactobacillus gasseri

tet(M), erm(B)

Dairy produce, Human

Lactobacillus johnsonnii

erm(B)

Animal, Human

tet(M)

Human

tet(M), erm(B)

Dairy produce, Fermented dry
sausage, Human

tet(S)

Human

cat-TC

Pork

tet(W), Inu(A)

Human

erm(B), erm(T), cat-TC

Animal

tet(M), erm(B)

Human

Lactobacillus plantarum

Lactobacillus reuteri

Lactobacillus rhamnosus
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A number of AMR genes are found in non-enterococcal LAB and Bifidobacteria spp.

Lactobacillus sakei

tet(M)

Fermented dry sausage

Lactobacillus salivarius

aaa(6’)-aph(2”), erm(B)

Animal

Lactobacillus spp.

erm(T)

Animal

tet(M), tet(O), tet(T)

Human

tet(K), tet(S), tet(W), tet(36)

Human

tet(M), tet(S), mdt(A), cat, str

Dairy produce

erm(T)

Animal

Leuconostoc citreum

tet(S)

Sausage Process line

Pediococcus acidilactici

erm(B)

Animal, Dairy produce

aaa(6’)-aph(2”)

Animal

Lactobacillus lactis

Resistance genes: aac, aminoglycoside
acetyltransferase; ant, aminoglycoside
adenylyltransferase; aph, aminoglycoside
phosphotransferases; cat chloramphenicol
acetyltransferase; erm, erythromycin resistant
gene; Inu, lincosamide resistance gene; mdt,
multiple drug transporter; str, streptomycin
resistant gene; tet, tetracycline resistant gene;
vat, streptogramin A acetyltransferase.
Conjugative plasmids for lactose utilization
(and/ or proteinase activity) were first reported
in Lactococcus lactis (Fitzgerald and Gasson,
1988). Since then, many R-plasmids have been
reported in Lactobacilli (reuteri, fermentum,
acidophilus, plantarum) and Lactococcus (lactis)
(Lin et al., 1996; Fons et al., 1997; Vescovo et al.,
1982, Danielsen, 2002), but the rates of plasmid
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transfer from these bacteria has been reported
to be low (Mathur and Singh, 2005). Two in-vitro
studies (Morelli et al., 1988; Igimi et al., 1996)
have examined conjugative transfer in the gut
microflora. A broad host range conjugative
plasmid (pAMß1), was transferred into L. reuteri
and L. lactis. These strains were then administered
orally or by gastric tube to mice and the faecal
contents were analysed to show plasmid transfer
into E. faecalis. Enterococci spp. are known to be
receptive for conjugation (Clewell and Weaver,
1989), but are also good at transferring antibioticresistant plasmids into Gram-negative (Courvalin,
1994) and Gram-positive bacteria (Perreten et al.,
1997), at rates of log10 10-4 to 10-9 transconjugants
per recipient, in LAB (Mathur and Singh, 2005).
While much attention has focused on antibiotic
resistance in enterocococci, more antibiotic
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resistance transfer studies are required in nonenterococcal LAB, to examine their potential role
in the dissemination of antibiotic resistant genes.
There are no reports linking conjugative
transposons and antibiotic resistance in LAB,
with the exception of those found in E. faecalis,
(Tn916, Tn918, Tn920, Tn925, and Tn2702), E.
faecium (Tn5233), S. pyogenes (Tn3701), and S.
agalactiae (Tn93951). These transposons have
been reported to carry resistance to tetracycline,
erythromycin, chloramphenicol and kanamycin.
Transposons also have the ability to mobilise
unrelated plasmids or other chromosomal genes
containing antibiotic resistance or virulence
genes. The transfer (in-vitro) of tetracycline
resistance (tet(M)) from E. faecalis to other LAB via
a transposon has been reported to be between
log10 10-6 to 10-9 transconjugants per recipient.
Impact of antimicrobial resistance in LAB
The widespread use of LAB and bifidobacteria
in fermented food and dairy products has a
safe history. While MDR is not common in
these isolates, LAB like all other bacteria, are
prone to gene exchange (Mathur and Singh.
2005). For these reasons, AMR will need to be
monitored in these isolates, so that no starter or
probiotic culture containing antibiotic-resistant
determinants are used in food production.
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Genetically Modified Organisms
(GMOs)
Under EU law a genetically modified organism
(GMO) is defined as an organism whose genetic
material has been altered in such a way that does
not occur naturally by mating and/or natural
recombination (Commission for the European
Communities, 2000). A number of concerns have
been raised about the use of this technology
including food safety issues, potential damage
to the environment, disruption of ecosystems,
as well as ethical and moral objections. In
particular, questions have been raised about
the relationship between antibiotic resistance
and this technology. By linking an antibiotic
resistant ‘marker gene’ to the ‘gene of interest’,
only cells that incorporate the new genes into the
bacterial cell will proliferate in the presence of an
antibiotic, while cells which have not accepted
the new genes fail to grow. Such a linkage has
specific operational advantages in the detection,
purification and cultivation of the “gene of
interest”, but may have negative effects in terms
of the transfer and dissemination of AMR.
There are many ways in which GMOs can
be produced, e.g., chromosomal alterations
(Johansen, 1999), recombinant DNA methods
(Curic et al., 1999), or introduction of additional
genes (Kondo and Johansen, 2002). Traditional
cloning vectors normally contain antibioticresistance determinants as selectable markers,
but these are considered unacceptable for
food use. Initially food grade selection was
based on nisin resistance (von Wright et al.,
1990), however intrinsic resistance to nisin in
L. lactis prevented further development of this

The risk of the transfer of AMR genes from genetically modified organisms to gut
micro-organisms is considered low.

marker. An alternative system is carried out by
deleting a ‘marker gene’ present in the bacteria
and reintroducing the same ‘marker gene’ on
a plasmid (McCormick et al., 1995). However,
this system has only been tested in laboratory
strains. Another system which has been tested
in industrial strains is the nonsense suppressor
tRNA located on a plasmid which suppresses a
nonsense mutation in the pyrF gene on the host
chromosome. The disadvantage is that specific
strains must be developed to act as a host for
the food-grade vector. Strains over expressing
aminopeptidases have been used successfully in
small-scale cheese production (Dickley et al., 1995;
Guldfeldt et al., 2001).
Impact of GMO’s in antimicrobial resistance
The risk of the transfer of AMR genes to gut
micro-organisms is considered low. However,
the use of AMR markers is being phased out and
replaced with other markers, such as those for
herbicide resistance. Currently, only four types
of GM crops may be found in food products on
the Irish market including soya bean, rape seed,
maize, and cotton seed), making up 0.5 per
cent of the total ingredient/food (FSAI, 2004).
All four crops are resistant to herbicides, with
the latter two resistant to pest attack. This is
in agreement with the ‘Guidance document
of the Scientific panel of Genetically Modified
Organisms for the Risk Assessment of Genetically
Modified Microorganisms and their Derived
Products Intended for Food and Feed Use’ (EFSA,
2006b), which recommends the use of alternative
technologies that do not rely on antibiotic
resistance markers. This guidance document
also considers information about location and
potential for transfer of each gene sequence. The
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phasing out of antibiotic-resistant marker genes
will eliminate the potential for dissemination
of resistance genes via GMO’s in the future. On
the request of the European Commission, the
European Food Safety Authority (EFSA) issued
an updated opinion in June 2009 on ‘marker’
genes, in particular antibiotic resistance marker
genes, present in GMO’s authorised in the EU. The
panels concluded that, according to information
currently available, adverse effects on human
health and the environment resulting from the
transfer of the two AMR marker genes, nptil and
aadA, from GM plants to bacteria, associated with
use of GM plants, are unlikely.
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...little information is available on the transfer of AMRt genes in food matrices.

5
Food processing technologies
Evidence of increased resistance to
food preservation stresses
Conjugation
Horizontal transfer of genes between different
species of bacteria (Neuwirth et al., 2001, Winokur
et al., 2001) is an evolutionary phenomenon
whose extent and significance has been subject
to intense debate. The maintenance and stability
of transferred genes suggests that they confer a
selective advantage on the recipient organism.
In most cases the nature of this advantage is
not understood, but the biological and clinical
significance of the transfer of AMR genes
remains clear (Koonin et al., 2002). Gene transfer
experiments have been carried out successfully in
several backgrounds including the intestines of
various animals (Bourgeois-Nicolaos et al., 2006),
in the human colon (Shoemaker et al., 2001) and
in cultured human cells (Ferguson et al., 2002).
Other environments investigated in a similar
manner included bovine rumen fluid (Mizan et al.,
2002), sewage (Ohlsen et al., 2003), surface water
(Arvanitidou et al., 1998) and calf faeces (Yates
et al., 2004). However, very little information is
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available on the transfer of AMRt genes in food
matrices. While several studies have successfully
demonstrated laboratory-based gene transfer
by conjugation with food-borne strains in broth
(liquid mating) (Allen and Poppe 2002; Chen et al.,
2004; Wilks et al., 2005) or by filter (solid surface)
mating (Pourshaban et al., 2002; Gevers et al.,
2003), data describing the in-situ food matrix is
limited (Cocconelli et al., 2003).
Walsh et al. (2008) reported the transfer of an
ampicillin-resistance marker via an R-plasmid
from S. Typhimurium DT104 to a susceptible
recipient E. coli K12 in broth, milk and ground
meat, at 25°C and 37˚C within 24-hour. A higher
rate of transfer (10-2 cfu g-1 transconjugants per
recipient) was reported in ground meat at 48
hour. Similarly, Van der Auwera et al. (2007)
reported plasmid transfer (at 10-1 cfu ml/g -1
transconjugants per recipient) for Bacillus
thuringiensis in broth, milk and milk pudding.
Cocconelli et al. (2003), reported the transfer
of vancomycin resistance via a conjugative
R-plasmid in enterococcal strains during cheese
and sausage fermentation. These authors
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reported a 2-3 log (cfu g-1) increase in the transfer
rate of plasmids in meat, and suggested that
factors including plasma in the meat matrix could
be important. These differences may depend on
the nature of the food matrix as human plasma,
since plasma is reported to have a positive effect
on plasmid transfer (Hirt et al., 2002).
Another recent study by McMahon et al. (2007)
showed increased rates (P<0.05) of resistance
transfer under typical food processing stresses
(high/low temperature, osmotic and pH stress),
compared to controlled conditions (McMahon
et al., 2007). These effects could be related to
increased activity or efficiency or one or more
of the steps involved in resistance transfer,
e.g. improved plasmid release/transfer or more
efficient plasmid capture under stress. Selective
pressures conferred by bacteriostatic, rather
then bactericidal food preservation protocols,
may be a driving force in the emergence of
antibiotic resistance among zoonotic pathogens.
However, to-date a knowledge gap exists on the
relationship between food preservation stress
and the transfer of antibiotic-resistance genes.
For this reason, the mechanisms, incidence,
and the epidemiological significance of stressenhanced transfer of AMR remain unknown.
Transformation
Several bacterial species are naturally
transformable, under a range of circumstances,
including specific chemical or physical conditions
(Davison et al., 1999). Food processing can
compromise the bacterial cell-membrane
integrity enhancing the uptake of resistance
genes on acquired extra-chromosomal DNA (Neu
et al., 1996). Transformation is enhanced by close
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contact with high concentrations of DNA and
environments rich in nutrients, such as, biofilms
(Baur et al., 1996), frequent circumstances
encountered in many parts of the food industry
environment (Arnold and Silvers, 2000).
Increased natural competence of bacterial cells
can be induced by salts, temperature shifts and
electro-shocks (Davis et al., 1999; Cérémonie et
al. 2004; 2006), although DNA released from
lysed bacterial cells is vulnerable to physical
degradation during processing. For example,
heat, shearing force, chemical degradation
and natural DNA-ases present in food, such as,
arginine, polyamines and biogenic amines (van
den Eede et al. 2004; Weiss et al. 2007). Thus,
food preservation technologies may injure cells
enhancing DNA release, but also modify such
DNA, allowing competent bacteria to acquire new
or modified characteristics, such as antimicrobial
resistance (IFT, 2006).
The development of competency and natural
transformation has been demonstrated in Bacillus
subtilis in milk (Zenz et al., 1998; Kharazmi et
al., 2002). However the extent to which food
processing contributes to the occurrence of
transformation in food is unknown.
Transduction
While there are many reports of transduction
of antibiotic-resistance genes within laboratory
studies, there is no information available on
transduction in the environment or in food. Its
importance as a mechanism for gene transfer is
questionable because of the high specificity of
the phages required (Ammor et al., 2007).

There is increasing concern that biocides may directly or indirectly stimulate the
development and emergence of antimicrobial resistance by inducing sublethal stress.

6
Sanitizing Agents
Increased restriction and/or prohibition of the use
of antibiotics as growth promoters, or hygiene
aids, has necessitated an increase in the use of
(alternative) biosecurity measures. These include the
application of biocides to reduce microbial numbers
which inevitably contaminate food processing
equipment, surfaces and environments (Karatzas
et al., 2007). These biocides differ from antibiotics
in that they are usually broad-spectrum chemical
agents, inhibiting or killing a wide range of microorganisms by non-specific means (White et al.,
2003). They are differentiated into disinfectants and
sanitizers based on testing, claims and directions for
use. Thus, a disinfectant must completely eliminate
all the organisms listed on its label (including fungi
and viruses), whereas a sanitizer need not eliminate
all target organisms to be effective, nor are fungi
and viruses ever included on a sanitizing claim.
Although biocides and antibiotics inactivate
bacteria in very different ways, there is
increasing concern that biocides may directly
or indirectly stimulate the development and
emergence of antimicrobial resistance by
inducing sublethal stress. Thus their increasing
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application in food processing and domestic food
preparation environments may be stimulating the
development and dissemination of antimicrobial
resistance in the human food chain. Biocide use
included surface treatment with; alcohol, oxidizing
compounds, hypochlorite, QACs, acid anionics,
acidified sodium chlorite and chloride dioxide, and
in hand care products e.g. triclosan, para-chlorometa-xylenol and chlorhexidine (IFT, 2006).

Biocides
The efficacy of biocides and the types of organisms
that they inhibit vary considerably and are
dependent on the compositional concentrations and
synergism among these components (Russell, 2000).
In contrast to antibiotics, biocides demonstrate a
non-specific killing by coagulation of the cytosol
and by damaging the cytoplasmic membrane.
This is in marked contrast with the highly specific
effects of antbiotics, many of which target very
specific mechanisms within target cells.
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Biocide resistance

Reports of biocide resistance

Resistance to biocides (disinfectants) is considered
to be unlikely to occur, as most disinfectants are
complexes of antimicrobial agents that inactivate
multiple cellular targets (McDonnell and Russell,
1999; Russell, 2003). These compounds can also
be applied at concentrations many times higher
than the minimum inhibitory concentration (MIC).
For this reason, decreased susceptibility does not
always confer decreased bactericidal activity (Jones,
1999). Factors reducing the effectiveness of biocides
include the presence of organic material and biofilm
growth (Gilbert and McBain, 2001). Inadequate
disinfection procedures in livestock production
facilities and food processing plants and
household environments may contribute to the
selection of biocide resistant isolates as a result of
exposure to sublethal biocide concentrations.

Staphylococci showing decreased susceptibility
to QACs have been isolated from food processing
plants (Sundheim et al., 1998; Heir et al., 2004).
Langsrud and Sundheim reported that more than
30 per cent of Pseudomonas spp. isolated from
poultry carcasses can grow in the presence of
benzalklonium chloride at concentrations used in
the poultry plant (Langsrud and Sundheim, 2004).
Resistance to QACs has been demonstrated in
Listeria spp. isolated from poultry products, red
meat and cheese (Lemaitre et al., 1998). In contrast,
a recent report showed that biocide resistance
was not a contributing factor to the persistence of
strains of L. monocytogenes and E. coli in the food
products and the environment of five chilled food
production facilities (Hojah, 2002), suggesting that
biocide resistance is only one of the factors involved
in pathogen selection/survival. Little is known about
the effects of low concentrations of biocides on
bacterial biofilms. It may be of potential significance
to the food industry that in-vitro studies found
incomplete elimination of biofilm by biocides. This,
in-turn, may lead to increased biocide resistance,
due to the selection of highly resistant clones
(McBain et al., 2003).
Biocides commonly used in the food industry
and in domestic settings
Biocides commonly used in the food industry
are listed in Table 12. Similar biocides are used in
a domestic environment, in particular triclosan,
QAC’s, chlorhexidine (Braoudaki and Hilton, (2004a),
hypochlorite (bleach) and chlorine (sometimes in
combination with zinc) (IFT, 2006).
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Inadequate disinfection procedures in livestock production facilities and
food processing plants and household environments may contribute to the
selection of biocide resistant isolates as a result of exposure to sublethal
biocide concentrations.

Table 12 Biocides commonly used in the food Industry

Active
ingredients

Environmental Food contact
surfaces
surfaces

Alcohols

+

+

Oxidising
compounds

+

+

Hypochlorite

+

+

+

-

-

Quaternary
ammonium
compounds

+

+

+

+

-

Phenolics

-

-

-

+

-

Acid anionics

+

+

-

-

-

Acified
sodium
chlorite

+

+

+

-

-

Chlorine
dioxide

+

+

+

-

-

Triclosan

-

-

-

-

+

Para-cholormeta-xylenol

-

-

-

-

+

Chlorhexidine

-

-

-

-

+
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Food tissues

Restroom

Handcare
+
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Triclosan
Triclosan is commonly used in handcare products
in the food industry. It works specifically on
enoyl-acyl reductase, an enzyme which is essential
for fatty acid synthesis. Modification, repression
or deletion of the specific cellular target fabI
(encoding enoyl-acyl reductase) results in reduced
bacterial susceptibility to triclosan (McMurray,
1998a; Gilbert and McBain, 2003; Randall, 2004)
in food pathogens (E. coli, Salmonella spp.
and Campylobacter spp.) and food spoilage (P.
aeruginosa) organisms. Additionally, many of
the Resistance-Nodulation-cell Division (RND)
family of pumps associated with resistance to
clinically-important antibiotics are able to expel
triclosan. These include the AcrAB-TolC pump
of E. coli (McMurray, 1998b) and Salmonella spp.
(Piddock, 2000), the CmeABC and CmeDEF of C.
jejuni (Pumbwe et al., 2005), and several of the Mex
pumps in P. aeruginosa (Chuanchuen et al., 2002).
Quaternary ammonium compounds
This group of biocide acts by physical disruption
and partial solubilisation of the cell wall and
membrane. For this reason, biocides are commonly
used on environmental and food contact surfaces
by the food industry. Resistance to QACs can be
mediated through the action of nonspecific efflux
pumps, along with other undesirable compounds
from the interior of the bacterial cell. Coding for
these pumps can be plasmid and chromosomally
located, and both types have been described in
both Gram-negative and Gram-positive bacteria
(Gilbert and McBain, 2003). As stated earlier, the
qacEð1 is mapped to the conserved segment (3’-CS)
of a class 1 integron structure. The chromosomal
efflux determinants of QAC resistance in Grampositive bacteria include the Major Facilitator
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(MF) family NorA multi-drug transporter (usually
associated with fluoroquinolone resistance), the
MF family MdeA, and the Multi-drug And Toxic
Compound Extrusions (MATE) family MepA in S.
aureus (Huang et al., 2004; Noguchi et al., 2004;
Kaatz, 2005). The main mechanisms of QAC
resistance is chromosomally mediated, whilst in
Gram-positive bacteria it is plasmid-borne, due
to the Small Multi-drug Resistance (SMR) family
transporters QacC/D and QacEΔ1, QacG, QacH
and QacJ and the MF family QacA/B transporter
(Poole, 2007). In contrast, the transporters capable
of exporting QACs in Gram-negative bacteria are
generally chromosomally encoded and include
a number of MATE (PmpM in P. aeruginosa), RND
(AcrAB-TolC, AcrEF-TolC and YhiUV-TolC pumps of
E. coli), (Poole, 2005) and SMR family (EmrE in E.
coli) (Yerushlmi et al.1995) multi-drug transporters.
The SMR transporters, QacE and QacEΔ1, QacF and
QacG found in Gram-negative bacteria are plasmidencoded (Paulsen et al., 1996; Poole, 2005).
Chlorhexidine
Chlorhexidine is used in hand-care products in
the food industry. Bactericidal concentrations
of chlorhexidine result in the denaturation
of cytoplasmic proteins and coagulation of
bacterial cell contents. The specific mechanism(s)
associated with chlorhexidine resistance remain
to be elucidated. However, chlorhexidine
resistance is associated with cepA, which
encodes a putative efflux mechanism in K.
pneumoniae (Fang et al., 2002). Benzalkonium
chloride and triclosan adapted E. coli, display
a multi-drug-resistance phenotype including
reduced susceptibility to chlorhexidine,
consistent with increased expression of an RND
multi-drug transporter (Braoudaki and Hilton,

The link between biocide exposure and the development of antibiotic resistance
remains to be conclusively established.

2005). Chlorhexidine has been shown to induce
expression of the MexCD-OprJ efflux pump in
P. aeruginosa (Morita et al., 2003) and QacA/B in
Gram-positive bacteria reduces susceptibility to
chlorhexidine (Morita et al., 2003; Poole, 2005).
Evidence of links between antimicrobial and
biocide resistance
The link between biocide exposure and the
development of antibiotic resistance remains
to be conclusively established. The theory of
cross-resistance (to antibiotics or biocides)
seems plausible; as resistance may be conferred
by a shared mechanism (e.g. efflux pumps).
Recent studies have shown that efflux pumps
(sometimes with unusually broad specifcities)
contribute to intrinsic resistance to agents,
such as, antibiotics, dyes and detergents
(Gilbert and McBain, 2003). Closer examination
of the mechanisms involved and the potential
role of efflux pumps might facilitate a clearer
understanding of this relationship, and provide
guidance on the appropriateness of such biocides,
particularly in line with their expanding use.
Triclosan resistance
Many efflux pumps which confer resistance to
triclosan also confer resistance to clinicallysignificant antibiotics. Karatzas et al. (2007)
reported that in-vitro exposure to triclosan
selected for Salmonella spp. with reduced
antibiotic susceptibility arising from the
overexpression of the AcrAB-TolC efflux pump.
Similar studies have reported the same findings
for E. coli (AcrAB-TolC) (Braoudaki, 2004a,
Braoudaki, 2004b), C. jejuni (CmeABC and
CmeDEF) (Randall et al., 2007), P. aeruginosa
(MexCD) (Chuanchuen et al., 2001) and S.
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maltophilia (SmeDEF) (Sanchez et al., 2005).
While not all RND exporters may be significant
determinants of triclosan resistance, their
ability to export antibiotics and triclosan,
highlights their potential contribution to the
development of cross-resistance. The extent
of this contribution requires epidemiological
investigation (Poole, 2005).
No relationship between the use of triclosan
and the development of antibiotic resistance
has been reported in household studies (using
products with/without triclosan) (Cole et al.,
2003). Moreover, a study conducted over a 10-year
period found no relationship between triclosan
use and antibiotic resistance in MRSA and P.
aeruginosa (Marshall et al., 2003). Since triclosan
is effective against a wide range of bacteria,
cross-resistance currently is not considered a
problem (Poole, 2005).
Quaternary ammonium compounds
and Chlorohexidine
Standard strains of E. coli, Salmonella spp.
and S. aureus are highly sensitive to QACs and
chlorohexidine and it is difficult to raise less
susceptible subcultures (Russell, 2003). However,
in vitro exposure to sub-lethal levels of QAC
has been shown to select for MDR (arising from
overexpression of the AcrAB-Tolc efflux pump) in
Salmonella spp. and E. coli (Braoudaki et al. 2004a,
2004b; Karatzas et al. 2007). The relationship
between chlorohexidine and RND transporters is
not as well studied, as that of QAC’s (Poole, 2005).
Triclosan and QAC adapted E. coli isolates exhibit
a MDR phenotype with reduced susceptibility to
chlorohexidine (Braoudaki et al., 2004a, 2004b).
However, chlorohexidine adapted E. coli isolates
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are not reported to exhibit an MDR phenotype
(Poole, 2005). Unlike the strains previously
discussed, P. stutzeri can be produced with
markedly less susceptibility to chlorohexidine
and QACs, in-vitro. These P. seudomonas stutzeri
isolates demonstrate cross-resistance to some
biocides and antibiotics (Tattawasart et al., 1999;
Tattawasart et al., 2000a, 2000b). This crossresistance is attributed to an alteration in the
cell’s outer membrane, resulting in a non-specific
decrease in cell permeability (Russell, 2003).
Many epidemiological studies have found no
relationship between biocide susceptibility and
antibiotic resistance to biocides commonly used
in hospital environments, including QACs and
chlorohexidine (Alqurashi et al., 1996; Suller et al.,
1999; Bacquero et al. 1991). However, a comparison
of clinical and industrial isolates of P. aeruginosa
revealed that clinical isolates had higher levels
of resistance to antibiotics. This was attributed
to the selective pressure of antibiotic use in
hospitals. However, the adaptive response of
P. aeruginosa to amikacin and tobramycin was
accompanied by a low-level increase in tolerance
to benzalkonium chloride (QAC) (Russell, 2003).
Numerous studies have clearly demonstrated
that selection for biocide resistance can
result in cross-resistance to antibiotics invitro (Moken et al., 1997, Braoudaki and Hilton,
2004a, 2004b). However, the true relationships
between biocide use and antibiotic resistance,
and the mechanisms involved, have as yet to be
confirmed in epidemiological studies.
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In addition to the health effects of AMR additional consequences are; infections
that would not otherwise occur; increased frequency of treatment failures; and
increased severity of infection.

7
Human health impact
Introduction
Humans can be exposed to antimicrobialresistant bacteria through food derived
from colonised animals, through increasing
antimicrobial resistance in the environment and
through food contamination during processing
[see section 4]. Environmental contamination
with resistant organisms, such as, surface waters,
has also been reported, giving rise to concerns
about direct exposure (Shea et al., 2004). An FAO/
OIE/WHO meeting (Geneva in 2003) concluded
that the emergence of antimicrobial-resistant
organisms associated with non-human usage of
antimicrobials posed adverse consequences to
human health. More recently, new EU regulations
banning the use of antibiotics as growth
promoters in animals have been introduced
in an attempt to reduce the emergence of
antibiotic resistance in the food-chain.
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Human health effects of
antimicrobial resistance
A CDC review reported on the extra human
health consequences of antimicrobial resistance
as opposed to the health effects caused by
susceptible organisms, and identified three
additional consequences: infections that would
not otherwise have occurred if the organisms
were not resistant; increased frequency of
treatment failures; and increased severity of
infection (Angulo et al., 2004).
Infections that would not have otherwise
occurred
When humans are taking antimicrobial medication,
they are at increased risk of infection with resistant
organisms, and in the US the number of additional
infections as a result of resistant organisms in
people taking antibiotics has been calculated
(Barza and Travers, 2002). For instance, an
additional 29,379 non-typhi salmonellae with 342
hospitalisations and 12 deaths were estimated to
occur, and the excess cases for C. jejuni infections
were calculated as 17,668 with 95 hospitalisations.

7

92

Human health impact

The increased severity of resistant infections has been demonstrated by greater
hospitalisation rates.

Additional vulnerability to infection, for food
animals receiving antimicrobials, may also result
in an increase in infection and transmission from
these animals (Angulo et al., 2004).
In the US, more than 400,000 extra days of
diarrhoea per year, and 8,677 extra days in
hospital, have been reported as attributable to
infection with resistant organisms, compared
with infection with susceptible organisms
(Travers and Barza, 2002).
Increased frequency of treatment failures
In a S. Typhimurium DT104 outbreak, two deaths
in patients treated with fluoroquinolones
were considered flouorquinolone-resistancerelated by the coroner (Angulo et al., 2004). In
the same review, it was reported that patients
taking fluoroquinolones, who have resistant
Campylobacter infection, have been found to have
several additional days of diarrhoea.
A potential lack of therapeutic options is a real
concern, for example, the drug of choice in the
treatment of children with invasive Salmonella
spp. disease, ceftriaxone, was not an option
in a child with ceftriaxone-resistant strain
of Salmonella spp. associated with the same
organism in a local outbreak of salmonellosis in
cattle (Fey et al., 2000).
Increased severity of infection
The increased severity of resistant infections has
been demonstrated by greater hospitalisation
rates, and greater case fatality rates (Angulo et al.,
2004). Increased risk of bloodstream infections
has also been seen, as well as death within 90
days (Angulo et al., 2004).
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Mortality associated with infections with
resistant organisms
Helms et al. (2002) found an increased risk of
death over two years in those infected with S.
Typhimurium –59 out of a total of 2047 patients
died as a result of S. Typhimurium. Even for
susceptible Salmonella spp. the risk of death
was 2.3 times more than for the general Danish
population (adjusted for age and co-morbidity).
With multi-resistance including quinolone
resistance, the risk of death increased by a factor
of 10.3 (95 per cent CI 2.8-37.8) (Helms et al., 2002).
Changes increasing the vulnerability of
host populations
As survival times following cancer treatment,
transplantation and other chronic diseases,
such as diabetes mellitus and autoimmune
diseases increases so does the pool of immunosuppressed patients alive in the community.
Improved life expectancy and the greater survival
of premature infants also increase the population
of those most vulnerable to any infections, and
particularly resistant infections.
Economic and other costs to health services
In the US, varying proportions of antimicrobial
use for veterinary purposes have been reported:
from 40 per cent of all antimicrobials used, with
only about a quarter of this used for therapeutic
reasons to 78 per cent of all antimicrobials use
being used in food animals for non-therapeutic
reasons (Shea et al., 2004). This indicates that
antimicrobial agent use in food animals is a
sizable problem and its side effects may present a
major challenge to veterinary public health.
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Human healthcare is costly and as a result,
resources must be managed in the most costeffective manner. Efforts to control antimicrobial
resistance through prudent use of antibiotics
and through ‘search and destroy’ policies are
threatened by imprudent use in human and
animal healthcare. In The Netherlands, for
instance, MRSA prevalence in farm families is
much higher than in the general population,
where human healthcare policies have been
successful and this new source of antimicrobial
resistance is outside the direct influence and
control of human health services.
Options are reduced in the treatment of AMR
resistant infections requiring the use of more
expensive and often toxic drugs. So even if an
effective alternative treatment is available, this
potentially avoidable cost could be prevented.
Infected individuals are a source of infection
for others, so prolonged illness, as occurs with
many resistant organisms, increases the cost
of isolation and other control measures. There
is also an increased risk of cross-infection and
outbreaks, which apart from the significant human
costs would escalate the economic impacts of
healthcare. This is very important as hospitals are
populated by particularly vulnerable people. Other
complicating factors need to be considered, for
example, increased hospital stays lead to increased
bed occupancy and possible overcrowding, which
increases the risk of cross-infection.
Increased morbidity and mortality, again apart
from the human cost to patients and their families,
are potential sources of litigation, which even if
negligence is not proven, are costly to defend.
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Opportunity costs – increased costs for
healthcare, longer hospital stays, more intensive
therapy, more expensive treatments, more
complications, more after-care divert the use
of scarce resources from other important
health needs, thereby using resources for other
healthcare provision, such as, cancer treatments
which cannot always be afforded.

Human antimicrobial resistance
surveillance:
There are two basic elements to human AMR
data, antimicrobial consumption data and data
on pathogen testing. There are well-recognised
limitations to the data sets both in terms of
accuracy and completeness. Some of these
include: lack of antimicrobial prescription, sale
and consumption data; only a limited number
of clinically important pathogens are tested for
resistance; sampling strategies and laboratory
methods are not standardised and not all isolates
are tested for all antimicrobials. A detailed review
of the available data is outside the scope of
this document. However, relevant data can be
sourced from the following websites: ESAC (EU
Surveillance of Antibiotic Consumption), ECDC,
EARSS, CDSCNI and HPSC.

Both SARI and AMRAP have recommended the development of guidance in
relation to the appropriate use of antimicrobials (in humans), as well as monitoring
the supply and use of antimicrobials in hospitals and the community.

8
Solutions
Prudent use of antimicrobial agents
On the island of Ireland there are two AMR
strategies, namely SARI (Strategy for the control
of Antimicrobial Resistance) in ROI and AMRAP
(Antimicrobial resistance Action plan) in NI.
Both SARI and AMRAP have recommended the
development of guidance in relation to the
appropriate use of antimicrobials (in humans),
as well as monitoring the supply and use of
antimicrobials in hospitals and the community
(NDSC, 2001). Education in relation to the human
health use of antimicrobials and hygiene were
also recommended and some materials have
been developed to assist with this. There have
also been two joint conferences aimed at
relevant professionals.
However, success in the implementation of
prudent prescribing of antimicrobials in human
healthcare is complex. Research has been
undertaken on prescribing practices focusing
on financial cost (Parrino, 1989), knowledge and
attitudes of physicians (Poses and Anthony, 1991;
Ehedahl et al., 1995) and the attitudes of patients
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or parents towards the inappropriate use of
antimicrobials (Palmer and Bauchner, 1997).
The most recent evidence indicates that even
when the need for rational prescribing is
accepted, there are ongoing challenges to achieve
best practice.
In veterinary practice, international guidelines on
the responsible and prudent use of antimicrobials
have been developed by the Office International
des Epizooties (Anthony et al., 2001).
According to a review by Collignon (Collignon
2004), there is an absence of evidence of any
significant benefit to agriculture from the use of
antimicrobials as growth promoters. Prohibiting
the use of antimicrobials as growth promoters
has a major effect on reducing the pool of
resistant organisms with minimal effect on
productivity (Wegener, 2003). Alternative animal
health care strategies have been proposed,
for example, because of resistance clustering
within herds, prevention strategies at herd level
interventions (Rosengren et al., 2008).
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The European Food Safety Authority (EFSA) has
reported that:

The existing human AMR surveillance systems are
briefly described in section 8 of this report.

“in terms of impact, controls operated at the
pre-harvest phase, for example, those aimed at
the control and limitation of antimicrobial usage
are potentially the most effective and as such are
capable of playing a major role in reducing the
occurrence of antimicrobial resistant bacteria in
food as presented for sale” (Scientific Opinion of
the Panel on Biological Hazards on a request from
the EFSA on foodborne antimicrobial resistance as
a biological hazard, 2008).

In animal health surveillance there is a less well
developed standardised surveillance system across
Europe. Surveys have been carried out in local
areas. In the ROI for example, monitoring of in-line
milk filters found Salmonella infection in six per
cent of herds, and all strains found were resistant
to at least one antibiotic (Murphy et al., 2008).

Need for on-going surveillance
Even with strict adherence to guidelines, as long
as antimicrobials are used at all, resistance will
remain a threat and, therefore, there is a need for
on-going human and animal surveillance, both
to monitor the outcomes of co-ordinated control
efforts and for the early identification of new
resistance threats.
EFSA has recommended:
“the development and application of new
approaches to the recognition and control of food
as a vehicle for antimicrobial resistant bacteria
and related genes based on epidemiological and
source attribution studies directed towards fresh
crop-based foods, raw poultry meat, raw pigmeat
and raw beef” (Scientific Opinion of the Panel on
Biological Hazards on a request from the EFSA on
foodborne antimicrobial resistance as a biological
hazard, 2008).
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The Community Summary Report on Trends
and Sources of Zoonoses Zoonotic Agents and
Antimicrobial Resistance in the European Union
was first published by EFSA in 2006.
Surveys have also been carried out internationally,
showing carriage of antimicrobial resistance
across species and across countries (Bywater et
al., 2004).
A model for continuous surveillance for
antimicrobial resistance among isolates from
food animals exists since 1995 in Denmark
(Aarestrup, 2004). The benefits of the Danish
surveillance system are felt internationally as
this source of surveillance data has informed
international scientific knowledge in recent years.
However, Aarestrup recommends: “an organised
monitoring of antimicrobial resistance carried out
by an international network” (Aarestrup, 2004).

Structured surveillance systems which integrate animal, human and food chain
surveillance across jurisdictions, are necessary to ensure effective public health
planning and intervention across the island of Ireland.

9
Recommendations
The recommendations below are grouped in to
two categories:- surveillance and research issues.
The surveillance issues focus on the crucial interlocking role of safefood between veterinary and
clinical medicine, to achieve an overall quality of
data for the people on the island of Ireland. The
research issues reflect specific research areas
in support of the particular role of safefood in
consumer protection.
Surveillance issues:
• Current levels and intensities of AMR
surveillance vary widely between the animal
population, the food chain, and the human
population. Much of such work is episodic,
with little or no ongoing surveillance or wider
harmonization across the island. Structured
surveillance systems which integrate the
above aspects, across jurisdictions, are
necessary to ensure effective public health
planning and intervention across the island
of Ireland.
• An integrated AMR monitoring programme,
with a clear emphasis on those areas that are
currently underdeveloped, i.e. food-borne
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•

•

•

AMR, should be developed on the island of
Ireland (e.g. DANMAP model). Food safety in
relation to AMR should be informed by risk
assessment of the impact of environmental
exposure to antimicrobial agents.
Integrated monitoring of antimicrobial
prescribing, dispensing and consumption
patterns in human and animal populations
on the island of Ireland is required. These
monitoring systems should be linked and
ongoing.
Programmes promoting the prudent use of
antimicrobial agents in animal and human
medicine on the island of Ireland should
link with all Food Safety agencies. Current
programmes promoting the prudent use of
antimicrobial agents (in both jurisdictions)
should be supplemented and extended, to
ensure adequate coverage in relation to the
food production, processing, and retail chain.
A Forum on Food Safety and AMR should be
established. Relevant stakeholders should
include policy makers, food industry, food
scientists, environmental protection agencies
and medical and veterinary professionals (a
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‘One Medicine’ approach). The forum should
be a collaborative network and have the
capacity to hold conferences, issue reports,
and act to ensure improved public safety in
relation to the risks posed by AMR bacteria in
the human food chain.
Research issues:
• Research into the potential dangers and
impacts of AMR on current and alternative
food technologies should be conducted in
association with food industry partners.
Initially, this work should focus on
technologies such as minimal processing and
probiotic supplementation of food products.
• Food attribution studies should be carried
out to estimate the fraction of food animal
associated AMR infections on the island of
Ireland with a view to supporting ongoing
identification and prioritisation of hazards
posed by (and interventions for the reduction
of) such AMR. These should be stratified
by populations and regions on the island
of Ireland, as the attributable fractions in
different communities, e.g.: urban versus
rural, are unlikely to be the same.
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Appendix
Table 1 Classes of antimicrobials, examples of substances used in human and veterinary medicine
and examples of resistance genes. (Modified from EFSA, 2007 – Opinion on foodborne antimicrobial
resistance as a biological hazard).
Note: There is generally complete or partial cross resistance within each class or subclass unless otherwise
indicated.
See Table 1 over leaf.
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Class

Aminoglycosides

Amphenicols

Beta-lactam
antibiotics
Penicillins

Examples of substances used in:
Human medicine

Veterinary medicine;
food production
animals in EU

neomycin,
spectinomycin

amikacin, gentamicin, apramycin,
netilmicin, tobramycin gentamicin,
streptomycin
kanamycin,
spectinomycin

chloramphenicol,
florfenicol,
tiamphenicol

benzyl-penicillin,
ampicillin, amoxicillin
(with clavulanic acid)

chloramphenicol,
tiamphenicol

Benzyl-penicillin,
ampicillin, amoxicillin
(with clavulanic acid)

blaZ (bla-PC), bla-TEM.
bla-SHV

cat, cfr, cml, flo

aac, aad (ant), aph,
armA, rpsL (strA) rpsD,
rpsE, strB

Resistance genes

Cross resistance
within sub-classes but
also, depending on
mechanism, between
subclasses

crf confers crossresistance to
amphenicols,
lincosamindes,
pleuromutilins,
streptogramins,
linezolid

No general crossresistance within
class, but some
types of resistance
will involve crossresistance between
some aminoglycosides

Comments
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cephalexin, cefazolin,
cephalotin

Cephalosporins, first
generation

cefazolin, cephalexin

cloxacillin,
dicloxacillin

cefoxitin

ertapenem, imipenem, meropenem

Bacitracin

teicoplanin,
vancomycin

Cephamycins

Carbapenems

Cyclic polypeptides

Glycopeptides
- (avoparcin)

(bacitracin)

cefepime, cefquinome

cefepime, cefpirome

Cephalosporins, fourth
generation

Ceftiofur

ceftazidime,
ceftriaxone

Cephalosporins, third
generation

Cephalosporins, second cefuroxime, loracarbef generation

cloxacillin,
dixcloxacillin
(methicillin)

Penicillins –
antistaphylococcal

van (A-E)

bcrABD

bla-IMP, bla-VIM, some
bla-OXA

bla-CMY, bla-AAC

bla-TEM. bla-SHV, blaCTX, bla-CMY, some
bla-OXA

bla-OXA, mecA

Formerly avoparcin
was used as feed
additive in EU

Formerly used as feed
additive in EU

Appendix

-

monensin,
salinomycin

Used as coccidiostats
cfr, erm

Cross-resistance also
to macrolides and
streptograminB for
certain resistance
genotypes

Ionophores

-

erm, ere, mef, msr

Cross-resistance also
to lincosamides and
streptograminB for
certain resistance
genotypes

clindamycin,
lincomycin

daptomycin

spiramycin, tylosin,
tulathromycin

Used formerly as
veterinary medicine

clindamycin,
lincomycin

Lipopeptides

erythromycin,
spiramycin,
azithromycin,
clarithromycin

-

Lincosamides

Macrolides &
ketolides

furazolidone,
nitrofurantoin

Used formerly as feed
additive

Nitrofurantoins

emtA

-

Avilamycin

cfr

Nitroimidazoles

-

-

metronidazole,
tinidazole

Orthosomycins

linezolid

Dimetridazole and
ronidazole used
formerly as veterinary
medicine

Oxazolidones
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-

colistin, polymixin B

nalidixic acid,
ciprofloxacin
norfloxacin,
moxifloxcin

-

pristinamycin,
quinpristin/
dalfopristin

sulfadiazine,
sulfamethoxazole,
trimethoprim

Pleuromutilins

Polymixins

Quinolones

Quinoxalines

Streptogramins

Sulphonamides &
trimethoprim

sulfadiazine,
sulfadoxine,
sulfamethoxazole,
trimethoprim

- (virginiamycin)

carbadox, olaquindox

danofloxacin,
enrofloxacin,

colistin, polymixin B

tiamulin, valnemulin

dfr, sul

cfr, erm, vga , vgb

oqxAB

aac(6’)-Ib-cr, gyrA.
parC, qepA, qnr,

cfr

Formerly virginiamycin
was used as feed
additive in EU
Cross-resistance
between
streptograminB,
lincosamides and
macrolides for certain
resistance genotypes

Olaquindox used
formerly as feed
additive in the EU

Incomplete crossresistance

Appendix

Tetracyclines

fusidic acid

fosfomycin

-

chlortetracycline,
doxycycline,
oxytetracycline

-

fusidic acid

-

flavophospholipol
(bambermycin)

chlortetracycline,
doxycycline,
oxytetracycline

mupA

fusB

fosAB

Rifampicin

-

(rifampicin)

cfr

rpoB

Use in vet. med
limited to foals

Used in human
medicine
topically for MRSA
decontamination

Used formerly as feed
additive

linezolid

tet

Miscellaneous

Mupirocin

Oxazolidones
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